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ABSTRACT 
Central line-associated bloodstream infections (CLABSIs) are one of the most 
significant healthcare-associated infections (HAIs) in the Intensive Care Unit (ICU) 
setting resulting in increased lengths of stay, increased healthcare costs, and higher 
mortality rates (Institute of Healthcare Improvement [IHI], 2012).  Evidence that 
CLABSIs are largely preventable has created opportunities for healthcare organizations 
to implement evidence-based bloodstream infection prevention practices to reduce or 
eliminate these infections (Lissauer, Leekisa, Prease, Thom, & Johnson, 2012).  Other 
efforts to reduce CLABSIs include implementation of safety programs to improve the 
safety culture in ICUs (Lissauer et al., 2012).  One program, the comprehensive unit-
based safety program (CUSP), was developed to improve the safety culture within ICUs 
and achieve the goal of reducing or eliminating CLABSIs (Pronovost et al., 2006).  The 
CUSP is a framework designed to educate and improve awareness of patient safety and 
quality of care for nurses, physicians, and other bedside care providers through a five step 
process (Agency for Healthcare Research and Quality [AHRQ], 2011).  The five steps of 
the CUSP program are:  (1) educate on the science of safety; (2) identify defects and 
patient safety hazards; (3) partner senior executive with a unit; (4) learn from defects; and 
(5) implement teamwork and communication tools (AHRQ, 2011).   
The seminal study by Pronovost et al. (2006) was conducted with a focus on 
reducing CLABSIs and improving the safety culture in 108 ICUs within the state of 
Michigan.  The study intervention targeted the use of bundled evidence-based 
bloodstream infection prevention practices in conjunction with implementation of the 
CUSP (Pronovost et al., 2006).  The study results demonstrated a 66% decrease from 
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baseline in the statewide CLASBI rates with continued sustainment at 18 months 
(Pronovost et al., 2006).  Success of this seminal study and others resulted in a national 
program called On the CUSP: Stop BSI formulated to reduce or eliminate CLABSIs in 
hospitals nationwide (AHRQ, 2012).  More than 1,000 hospitals participated in this 
program and achieved success in reducing nationwide CLABSI rates by 41% (AHRQ, 
2012). 
The reduction of CLABSIs through multiple collaborative cohort studies has been 
attributed to the use of evidence-based prevention bundles and improvement in the 
healthcare safety culture.  The CUSP framework has been validated as an essential factor 
in the success of CLABSI reduction efforts.  Continued progress in the reduction of 
CLABSIs emphasizes the preventability of these infections and will accelerate progress 
toward elimination. 
The purpose of this project was to reduce or eliminate CLABSIs in the ICUS 
within our national investor-owned 49 hospital healthcare system through the 
implementation of the CUSP framework.  The impact of the CUSP was evaluated using a 
pre-and post-implementation comparison of hospital CLABSI rates.  Data was reported 
for 65 ICUs, representing 41 hospitals across the baseline pre-and post-CUSP 
implementation time periods.  The total number of CLABSIs reported for the baseline 
pre-CUSP implementation time period of September 2012 to January 2013 was 71, with 
an infection rate of 1.10 per 1,000 catheter days.  The data for the post-CUSP 
implementation time period of August 2013 to December 2013 revealed a decrease in the 
total number of CLABSIs to 42, and a resultant decrease in the infection rate to 0.73 per 
1,000 catheter days.  This decrease represented a 32.8% reduction in CLASBIs post-
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CUSP implementation.  The evaluation of the CUSP implementation success through the 
reduction or elimination of CLABSIs validated the potential replication of a systematic 
approach to address additional quality improvement (QI) initiatives throughout our 
healthcare system.     
 
 
  
 vi
  
 
 
 
 
 
 
 
 
 
~Dedication~ 
I dedicate this doctoral scholarly project to my partner whose support and encouragement 
along this journey was deeply appreciated.  I also dedicate this doctoral scholarly project 
posthumously to my loving parents, Lloyd James and Helen Hresko Basinger, who 
always believed in me. 
  
 vii
  
TABLE OF CONTENTS 
ABSTRACT ………………………………………………………………………. iii 
LIST OF FIGURES ……………………………………………………………….. ix  
LIST OF TABLES ………………………………………………………………… x   
CHAPTER I – INTRODUCTION AND PROBLEM STATEMENT ……………  1 
 Introduction ……………………………………………………………....  1 
 Problem Statement………………………………………………………..  3 
CHAPTER II – REVIEW OF THE LITERATURE ………………………….......  5 
 CLABSI Multifaceted Intervention Studies ……………………………….  5 
 Comprehensive Unit-Based Safety Program (CUSP) ……………………. 10 
 Needs Assessment and Description of the Project ……………………….. 12 
  Population Identification …………………………………………. 12 
  Project Sponsor and Key Stakeholders …………………………… 13 
  Organizational Assessment ……………………………………….. 14 
  Team Selection and Formation …………………………………… 15 
  Scope of the Project ……………………………………………….. 16 
  Effects on the Healthcare System …………………………………. 16 
 Mission, Goals, and Objectives Statements ………………………………. 17 
  Mission ……………………………………………………………. 17 
  Goals ……………………………………………………………… 18 
  Objectives ………………………………………………………… 18 
CHAPTER III – THEORETICAL UNDERPINNINGS OF THE PROJECT ……. 19 
 Theoretical Framework …………………………………………………… 19 
 Program Framework ……………………………………………………… 22 
 
CHAPTER IV – PROJECT AND EVALUATION PLAN……………………….. 25 
 Project Plan ……………………………………………………………….. 25 
  CUSP Project Overview ………………………………………….. 25 
  Setting …………………………………………………………….. 26 
  Population of Interest …………………………………………….. 26 
  Measures, Instruments, and Activities …………………………… 27 
  Timeline and Project Tasks ………………………………………. 28 
  Risks and Threats ………………………………………………… 28 
 Evaluation Plan …………………………………………………………… 29 
  Financial Plan …………………………………………………….. 30 
  Institutional Review Board (IRB) ………………………………… 31 
  Maintaining/Sustaining the Change ………………………………. 31 
 viii
  
CHAPTER V – SUMMARY OF IMPLEMENTATION AND RESULTS ……… 33 
 Initiation of the Project ……………………………………………………. 33 
 Threats and Barriers to the Project ……………………………………….. 34 
 Monitoring of the Project ………………………………………………… 36 
 Data Collection …………………………………………………………… 37 
 Data Analysis …………………………………………………………….. 38 
 Giving Meaning to the Data ……………………………………………… 39 
  Results ……………………………………………………………. 39 
  Discussion ………………………………………………………… 44 
  Study Limitations ………………………………………………… 45 
  Conclusion ……………………………………………………….. 47 
  Dissemination and Utilization of Results ………………………… 48 
APPENDICES ……………………………………………………………………. 49 
 Appendix A   CUSP Team Membership Guidelines …………………….. 49 
 Appendix B   Guidelines for Key Messages-Senior Leader Sponsorship... 50 
 Appendix C   CUSP Course Content and Objectives …………………….. 52 
 Appendix D   Central Line Insertion Care Team Checklist ……………… 54 
 Appendix E   Biomedical IRB Notice of Excluded Activity …………….. 55 
 Appendix F   Team Ground Rules Sample ……………………………… 56 
 Appendix G   CUSP Team Meeting #1 Agenda Sample …………………. 57 
 Appendix H   CUSP Team Meeting #1 or #2 Agenda Sample ………….. 58 
 Appendix I    CUSP Team Meeting #2 or #3 Agenda Sample ………….. 60 
 Appendix J    CUSP Team Meeting #3 or #4 Agenda Sample ………….. 61 
 Appendix K   CUSP Team Meeting #4 or #5 Agenda Sample ………….. 62 
 Appendix L   CUSP Team Meeting #5 or #6 Agenda Sample ………….. 63 
 Appendix M   Staff Safety Assessment – CUSP …………………………. 64 
 Appendix N   Attendance Sheet-Science of Safety/Safety Assessment …. 65 
 Appendix O   Learn From Defects Tool Worksheet …………………….. 66 
 Appendix P   CUSP Webinar Team Attendance List ……………………. 67 
 Appendix Q   Permission …………………………………………………. 68 
 Appendix R Figures and Tables ………………………………………… 69 
  
 
REFERENCES …………………………………………………………………… 83 
VITA ……………………………………………………………………………… 90 
 
           
 
 
 
 ix
  
LIST OF FIGURES   
Figure 1 Individual Hospital CLABSI Rate Comparison Pre-and  
  Post-CUSP Implementation ………………………………………. 40 
Figure 2 CLABSI Rates Trended Comparison 1
st
 Q 2012 – 4th Q 2013 …… 41 
Figure 3 Overall Webinar Attendance and Post-CUSP Implementation 
  CLABSI Rates ……………………………………………………. 42 
Figure 4 Webinar Attendance by Category ………………………………… 43 
Figure 5 Model of Five Stages in the Innovation-Decision Process ……….. 69 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 x
  
LIST OF TABLES 
Table 1 CLABSI Rate Comparison Pre-and Post-CUSP Implementation … 39 
Table 2  Comparison of Pre-and Post-CUSP Implementation Rates by 
  Attendance Category ……………………………………………… 43 
Table 3 Diffusion of Innovations Linkage to CUSP ………………………. 70 
Table 4 Detailed Timeline …………………………………………………. 71 
Table 5 Team Leader Checklist – Webinar #1 …………………………….. 75 
Table 6 Team Leader Checklist – Webinar #2 …………………………….. 76 
Table 7 Team Leader Checklist – Webinar #3 …………………………….. 77 
Table 8 Team Leader Checklist – Webinar #4 …………………………….. 78 
Table 9 Team Leader Checklist – Webinar #5 …………………………….. 79 
Table 10 Team Leader Checklist – Webinar #6 …………………………….. 80 
Table 11  Poisson 95% Confidence Intervals by Hospital …………………... 81 
Table 12 CLABSI Rates and Webinar Attendance …………………………. 82 
     
 
  
 1
  
CHAPTER I – INTRODUCTION AND PROBLEM STATEMENT 
Introduction 
 Central venous catheters (CVCs) are integral to the care of adult patients in 
Intensive Care Units (ICUs).  CVCs provide vascular access for the administration of 
fluids, medications, total parenteral nutrition (TPN), blood products, and for 
hemodynamic monitoring and blood sampling (Kim, Holtom, & Vigen, 2011).  
Approximately 48% of all patients in ICUs have CVCs which translates into an estimated 
15 million catheter days per year (Centers for Disease Control and Prevention [CDC], 
2011).  Although CVCs provide reliable vascular access, there are associated risks with 
their use.  The most common risk associated with CVCs is central line-associated blood 
stream infections (CLABSIs) caused by microorganisms colonizing the external surface 
of the device or the fluid pathway when the device is inserted, or in the course of its use 
(Institute for Healthcare Improvement [IHI], 2012).  CLABSIs are defined as laboratory-
confirmed bloodstream infections associated with CVCs when a CVC has been in use 48 
hours prior to the onset of an infection with no apparent source except the CVC (O‟Grady 
et al., 2011).  In 2009, approximately 18,000 CLABSIs occurred in ICU patients with 
CVCs (CDC, 2011).  According to the IHI (2012), approximately 90% of all CLABSIs 
occur due to CVC use, resulting in increased lengths of stay, increased costs, and higher 
mortality rates.  CLABSIs are one of the most significant healthcare-associated infections 
(HAIs) in the ICU setting, representing 10% to 20% of all HAIs (Bianco, Coscarelli, 
Nobile, Pileggi, & Pania, 2013).  These infections are the leading cause of death among 
HAIs with reported mortality rates of 12% to 25% in adult ICU patients (Marra et al., 
2010).  CLABSIs are a significant source of preventable morbidity and mortality 
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responsible for approximately 28,000 deaths annually in the United States (Lissauer, 
Leekisa, Preas, Thom, & Johnson, 2012).  In addition, CLABSIs represent a significant 
economic burden for healthcare organizations, prolonging a patient‟s hospitalization an 
average of seven days with an episodic cost of approximately $45,000 (Lissauer et al., 
2012).  The estimated annual cost of CLABSIs to the healthcare system in the United 
States is $2.3 billion (Pronovost, Marsteller, & Goeschel, 2011).  As a result of these 
findings, The Joint Commission (TJC) mandated hospitals to implement protocols by 
January 1, 2010 that meet the requirements of the CLABSI national patient safety goal 
(NPSG) 7, the reduction of CLABSIs (TJC, 2010).    
 Evidence that HAIs are largely preventable has created opportunities to 
implement practices to reduce or eliminate the burden associated with such infections.  
CLABSIs are customarily preventable with adherence to evidence-based preventative 
guidelines (Kusek, 2012).  As such, many healthcare organizations have undertaken 
efforts to reduce the incidence of CLABSIs to include the use of evidence-based central 
line insertion bundles (Lissauer et al., 2012).  The IHI (2012) defines a care bundle as a 
set of three to five practices that have been proven to improve patient outcomes when all 
components are completed together every time.  Care bundles can benefit patient care by 
delivering evidence-based practices to the bedside and ensuring uniform application of 
best practices to all patients (McPeake, Cantwell, Booth, & Daniel, 2012).  Bundle 
approaches are broadly accepted as the standard model for prevention of CLABSIs with 
concentrated strategies on physician and patient preparation (Worth & McLaws, 2012).  
The five evidenced-based procedures recommended by the CDC and identified as having 
the lowest barriers to implementation and the greatest effect on the rates of CLABSIs are 
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(1) hand hygiene prior to catheter insertion; (2) use of maximal sterile barrier 
precautions; (3) chlorhexidine for skin antisepsis; (4) avoidance of the femoral site for 
insertion; and (5) prompt removal of catheters when no longer indicated (Agency for 
Healthcare Research and Quality [AHRQ], 2013).    
 Other efforts to reduce the incidence of CLABSIs, in addition to the use of 
evidence-based central line insertion bundles, include the implementation of safety 
programs to improve the safety culture within ICUs (Lissauer et al., 2012).  One program, 
the comprehensive unit-based safety program (CUSP), was designed to improve the 
safety culture and includes communication and teamwork toward the common goal of 
eliminating CLABSIs (Pronovost, 2008).  The CUSP program provides a pragmatic 
framework and tools that caregivers at the unit level can utilize to improve teamwork and 
relationships with senior hospital executives, to identify and resolve safety hazards, and 
to foster a culture of safety (Pronovost et al., 2008).      
 Although attempts to reduce the incidence of CLABSIs have been successful, 
CLABSIs continue to be identified (Marra et al., 2010).  CLABSIs represent a principal 
challenge that result in significant morbidity, mortality, increased length of stay (LOS), 
and economic losses (Bianco et al., 2013).  Reducing CLABSI rates in an ICU setting is a 
complex process that involves multiple performance measures and interventions (Marra 
et al., 2010). 
Problem Statement   
 This project was conducted in a national investor-owned corporation comprised of 
49 acute care hospitals and various other comprehensive healthcare services including 
ambulatory surgery centers, free-standing emergency departments, urgent care centers, 
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and diagnostic centers.  Despite the implementation of central line bundles within our 
healthcare system, the CLABSI rates continued to prevail.  Of the 49 acute care hospitals, 
41 have CLABSI rates at greater than the system wide established target of 0.31 per 
1,000 device days.  This target is set at the standardized rates for CLABSIs in accordance 
with the CDC and through the National Health and Safety Network (NHSN) top 25
th
 
percentile benchmark (Dudeck et al., 2011).  Although the use of evidence-based 
bloodstream infection prevention practices has reduced the number of CLABSIs in our 
ICUs, they have not been eliminated.  Previous studies have been unable to determine if 
these remaining CLABSIs represent failures of the evidence-based bundle application or 
other patient associated risk factors related to their hospitalization (Lissauer, Leekisa, 
Preas, Thom, & Johnson, 2012).  Baseline random observations of the evidence-based 
bundle utilization revealed inconsistent application and compliance in several of the ICUs 
within our healthcare system.  Attempts to develop a valid and feasible measure of 
consistent compliance with evidence-based practices for CVC insertions have not been 
successful (Pronovost, Berenholtz, & Needham, 2008).  CVCs are often placed randomly 
which makes the coordination of independent observations difficult, and self-reported 
compliance often overrates performance (Pronovost, Berenholtz, & Needham, 2008).  
Sustainment of lower CLABSI rates and progression toward elimination will require a 
focused commitment of our healthcare system hospitals.   
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CHAPTER II – REVIEW OF THE LITERATURE 
CLABSI Multifaceted Intervention Studies 
 There have been many studies documented in the literature regarding the 
reduction of CLABSIs in ICUs nationwide.  The majority of the studies have reported 
statistically significant decreases in CLABSI rates post-implementation of a quality 
improvement (QI) initiative (O‟Grady et al., 2011).  Some studies used approaches in 
which multiple strategies have been implemented together to improve compliance with 
the use of evidence-based guidelines.  A seminal study conducted by Pronovost et al. 
(2006), known as the Keystone ICU project, included a collaborative cohort of 108 ICUs 
within the state of Michigan.  The strategies in this study included the use of five 
evidence-based bloodstream infection prevention practices for CVC insertions, use of a 
checklist to ensure adherence and compliance to proper practices, and implementation of 
the CUSP to improve the safety culture (Pronovost et al., 2006).  The period required for 
the implementation of each intervention was estimated to be three months and all 
hospitals started with implementation of the CUSP (Pronovost et al., 2006).  Coterminous 
with the intervention, the median rate of infection decreased from 2.7 per 1,000 catheter 
days at baseline to zero within the first three months after the implementation of the 
intervention (Pronovost et al., 2006).  The benefit from the intervention was sustained as 
the study results revealed a 66% decrease in statewide CLABSI rates from baseline at 16 
to18 months post-implementation of evidence-based interventions (Pronovost et al., 
2006).  This study also emphasized how technical and adaptive components were needed 
to successfully implement a CLABSI prevention initiative (Pronovost, Berenholtz, & 
Needham, 2008).    
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 Identifying methods for the sustainment of results from QI initiatives is important 
for the generalizability of research findings.  A second collaborative cohort study was 
conducted by Pronovost et al. (2010) to evaluate the extent to which the participating 
ICUs in the initial Keystone ICU project had continued to sustain reductions in their 
CLABSI rates.  As the participating Michigan ICUs continued to integrate the evidence-
based interventions into practice, the study results revealed that the reduced CLABSI 
rates achieved in the initial 18 month post-implementation period were sustained for an 
additional 18 months (Pronovost et al., 2010).  The median rate of infection remained at 
zero for the 18 month sustainability period with an over 60% CLABSI rate reduction at 
the end of the 36 month period (Pronovost et al., 2010).  Sustainment of the results was 
attributed to ongoing feedback of progress through the reporting of infection data, 
improvements in the safety culture, maintaining the assembled teams, an assiduous belief 
in the preventability of CLABSIs, and continuing staff education (Pronovost et al., 2010).  
The results of these two collaborative cohort studies indicate that the broad use of the 
evidence-based interventions with achievement of comparable results could reduce the 
morbidity and costs associated with CLABSIs (Pronovost et al., 2010).     
 As results of the success with the seminal Keystone ICU project were 
disseminated, other healthcare organizations sought to evaluate and replicate the 
multifaceted intervention designed to improve the safety culture and the use of evidence-
based bloodstream infection prevention practices to reduce CLABSIs.  The Rhode Island 
(RI) ICU collaborative was created in 2005 as a QI platform to explore the replication of 
the Michigan Keystone ICU project (DePalo et al., 2010).  Data was collected from the 
23 ICUs in the 11 RI hospitals from January 2006 through June 2008.  As in the 
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Keystone ICU project, each participating ICU implemented the bundled evidence-based 
bloodstream infection prevention practices and introduced the CUSP at the launch of the 
collaborative (DePalo et al., 2010).  The statewide median rate of infection decreased 
from 1.95 per 1,000 catheter days at baseline to zero by March 2008 (DePalo et al., 
2010).  Study results revealed the use of a multifaceted intervention was associated with a 
74% statewide CLABSI reduction and demonstrated the results achieved in the Keystone 
ICU project could be extended and replicated in RI (DePalo et al., 2010). 
 The first randomized controlled experimental evaluation using a multifaceted 
intervention involving a bundle of evidence-based bloodstream infection prevention 
practices and the CUSP to improve safety, teamwork, and communication was conducted 
in 45 ICUs from 35 hospitals within two Adventist healthcare systems (Marsteller et al., 
2012).  The intervention group started in March 2007 and the control group started seven 
months later in October 2007, with the study period ending in September 2008 
(Marsteller et al., 2012).  The median CLABSI rate in the intervention group decreased 
from 2.56 per 1,000 catheter days at baseline to zero at the end of the study period 
(Marsteller et al., 2012).  Similar results occurred in the control group with the median 
CLABSI rate decreasing from 1.78 per 1,000 catheter days at baseline to zero at the end 
of the study period (Marsteller et al., 2012).  This study demonstrated a causal 
relationship between use of the CUSP and the evidence-based infection prevention 
intervention and reduced CLABSIs in participating ICUs (Marsteller et al., 2012). The 
intervention group achieved a 70% reduction in CLABSI rates which were sustained at 
19 months post-implementation with similar results replicated in the control group 
(Marsteller et al., 2012).  This study established that the CLABSI rate reduction through 
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the implementation of the CUSP and the use of evidence-based bloodstream infection 
prevention practices were sustainable and able to be replicated (Matsteller et al., 2012).   
 After the replication of the Pronovost and colleagues studies (Pronovost et al., 
2006 & 2010) in the RI ICUs and the two Adventist healthcare systems, the AHRQ 
funded and launched this program for implementation and dissemination throughout the 
United States (Sawyer et al., 2010).  A two-year program called On the CUSP: Stop BSI 
was formulated in 2008 to prevent CLABSIs in hospitals nationwide and was organized 
as a state or region-level collaborative with centralized education, data collection, and 
program management functions (AHRQ, 2012).  More than 1,000 hospitals and 1,800 
hospital units, representing a total of 44 states, the District of Columbia, and Puerto Rico, 
participated in the program (AHRQ, 2012).  The program structure included three main 
components:  (1) a model to translate evidence into practice at the bedside to prevent 
CLABSIs; (2) the CUSP to improve the safety culture; and (3) a system to measure and 
report infection data (Sawyer et al., 2010).  Results of the program revealed success in 
reducing CLABSIs nationwide by 41% from a baseline of 1.915 infections per 1,000 line 
days to a rate of 1.133 infections (AHRQ, 2012).   
 With the nationwide success of the On the CUSP: Stop BSI program (AHRQ, 
2012), the state of Hawaii embarked on their own study to determine if a national ICU 
collaborative to reduce CLABSIs would succeed in the state (Lin et al., 2012).  The 
study, which began in January 2009 and ended in December 2010, included the CUSP, a 
multifaceted intervention approach to CLABSI prevention, and infection rate monitoring 
(Lin et al., 2012).  Data was collected and reported from 20 ICUs representing 16 
hospitals across the state (Lin et al., 2012).   The results revealed the overall mean 
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statewide CLABSI rates decreased 61% from 1.5 infections per 1,000 catheter days at 
baseline to 0.6 at 16 to 18 months post-implementation of the project, reinforcing the 
evidence that the On the CUSP: Stop BSI program can succeed in other states and 
substantially reduce CLABSI rates in hospitals (Lin et al., 2012).   
 The success of the initial Hawaii study was the catalyst to conduct a second study 
in the state.  This cohort study continued the national On the CUSP: Stop BSI program 
interventions, extended the program beyond the adult ICUs, and implemented a series of 
tools to improve the maintenance of CVCs and sustain the collaborative model (Lin, 
Weeks, Holzmueller, Pronovost, & Pham, 2013).  A total of 38 clinical areas were 
included in this study:  the original 20 ICUs, 10 adult medical/surgical units, two 
operating room (OR) suites, two pediatric ICUs (PICUs), two neonatal ICUs (NICUs), 
and two emergency departments (Eds) (Lin et al., 2013).  The 18 month time period for 
this phase of study was from January 2011 through June 2012.  The CLABSI rates in the 
adult ICUs decreased from1.49 infections per 1,000 catheter days at baseline to 0.25 by 
the end of this study phase, signifying an 83% decrease for the 36 month study period 
(Lin et al., 2013).  The CLABSI rates in the non-adult ICUs and the non-ICU clinical 
areas decreased from 2.54 infections per 1,000 catheter days at baseline to 0.33 by the 
end of this study phase, signifying an 87% decrease in the infection rate (Lin et al., 2013).  
The second Hawaii cohort study demonstrated successful extension of the program 
beyond the adult ICUs, continued sustainment of decreased statewide CLABSI rates, and 
the impact of the CUSP on the statewide ability to reduce infections (Lin et al., 2013). 
 The successes of the numerous studies conducted on the effects of multifaceted 
interventions to reduce CLABSIs, along with the nationwide success of the On the 
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CUSP: Stop BSI program (AHRQ, 2012), continued to influence additional healthcare 
organizations to seek opportunities to participate in collaboratives designed to reduce 
CLABSI rates.  The state of Connecticut entered into a study to determine whether the 
multifaceted intervention from the Michigan Keystone ICU program could be 
implemented in the state with similar impact on ICU CLABSI rates (Hong et al., 2013).  
Seventeen ICUs from 14 hospitals within the state participated in the collaborative that 
included the multifaceted intervention to prevent CLABSIs, implementation of the 
CUSP, and measurement and performance feedback of CLABSI data (Hong et al., 2013).  
Participating hospitals and ICUs reported baseline data for May 2008 to April 2009 and 
post-implementation data for May 2009 to January 2011 (Hong et al., 2013).  The overall 
mean (median) CLABSI rates in the 17 ICUs decreased from 1.8 (1.8) infections per 
1,000 catheter days at baseline to 1.1 (0) at post-implementation of the intervention in 
January 2011 (Hong et al., 2013).  The overall mean CLABSI rate was decreased by 41% 
which, once again, demonstrated that the Michigan Keystone ICU program could be 
replicated with associated reductions in CLABSIs (Hong et al., 2013).        
Comprehensive Unit-Based Safety Program (CUSP)   
 Improving communication, teamwork, and the culture of safety in the ICUs was 
an integral part of the success in the CLABSI rate reduction studies and the eventual 
sustainment of the gains.  These studies incorporated a technical component through the 
use of evidence-based practices and an adaptive, innovative component through use of 
the CUSP to successfully achieve the results (AHRQ, 2012).  The Institute of Medicine 
(IOM) report To Err is Human (2000) identified patient safety as a nationwide issue and 
indicated improvement endeavors should focus on systems such as technology, practices, 
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procedures, and the culture in healthcare organizations.  As a result, healthcare 
organizations began to implement initiatives to improve patient safety.  One major 
initiative was the seminal study by Pronovost et al. (2005) to develop, implement, and 
validate the CUSP.  The program was initially developed as an eight step process 
designed to impact the safety climate by staff empowerment and responsibility for safety 
in their environment (Pronovost et al., 2005).  The eight step process in the program 
includes: (1) conduct a cultural survey; (2) educate staff on sciences related to safety; (3) 
identify the safety concerns of staff members; (4) senior executive adoption of a working 
unit; (5) implement improvements; (6) document results; (7) share stories; and (8) repeat 
the cultural survey (Pronovost et al., 2005).  A pre-and post-implementation evaluation of 
the CUSP in two ICUs at Johns Hopkins Hospital resulted in safety culture improvement 
in both units and an associated reduction in ICU length of stay (LOS), medication errors, 
and nursing turnover (Pronovost et al., 2005).  Based upon these results, the CUSP was 
disseminated to other units and clinical areas throughout the hospital with similar results 
(Pronovost et al., 2005).  The CUSP was subsequently truncated into five sequential steps 
to facilitate utilization into the daily routines of staff members (Timmel et al., 2010).  The 
five sequential steps include:  (1) science of safety training; (2) identify safety hazards; 
(3) senior executive partnership; (4) learn from defects; and (5) implement teamwork and 
communication tools (Timmel et al., 2010).    
 A second study was conducted to validate the Pronovost et al. study (2005) and to 
evaluate the impact of the CUSP on the safety climate in a large ICU collaborative cohort 
(Sexton et al., 2011).  This study further linked safety climate to clinical and operational 
outcomes and demonstrated that safety climate is responsive to interventions (Sexton et 
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al., 2011).  Study results revealed significant improvements in the safety climate from 
42.5% to 52.2% and provided further evidence that use of the CUSP and focused 
interventions to reduce bloodstream infections was associated with the resultant 
decreased CLABSI rates (Sexton et al., 2011).       
 In conclusion, the reduction of CLABSIs has been attributed to various factors 
including evidence-based prevention bundles, education in prevention efforts, statewide 
and national collaborative programs, and improvement in the healthcare safety culture.  
The CUSP framework has been demonstrated and validated to be an essential component 
of the successful CLABSI reduction efforts.  Continued progress in the reduction of 
CLABSIs emphasizes the preventability of these infections and will accelerate progress 
toward elimination.  
Needs Assessment and Description of the Project 
Population Identification 
 The target population identified in this project will include registered nurses 
(RNs), physicians, and other healthcare team members who provide direct care to adult 
ICU patients with CVCs.  Other healthcare team members who provide direct care to 
adult ICU patients include nurse practitioners (NPs), physician assistants (PAs), 
respiratory therapists (RTs), and nurse technicians (NTs).  The patient population 
identified in this project will include all adult patients with a CVC in the ICU.  The 
corporate clinical operations executives of our healthcare system elected to exclude 
patients admitted to a Pediatric Intensive Care Unit (PICU), Neonatal Intensive Care Unit 
(NICU), or any other clinical department outside of the adult ICUs to mitigate 
confounding from multiple settings.  This decision was also in congruence with the 
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model established for the numerous collaborative cohort studies conducted to reduce 
CLABSIs.      
Project Sponsor and Key Stakeholders  
 The patient, as the recipient of care, is the most important stakeholder in this 
project.  Understanding the needs and potential contribution of all other stakeholders is an 
important component of this project.  Team building is an essential part of the CUSP 
program as this approach empowers healthcare team members and eliminates the 
traditional hierarchal decision-making in hospitals (Evans, 2012).  The identification and 
involvement of senior executive leadership is critical to provide authorization for 
potential resources required to assist in the resolution of unit-based patient safety issues 
(Evans, 2012).  The identified healthcare system sponsor for this project is the Vice 
President of Quality.  She will work with the project leader, the Doctor of Nursing 
Practice (DNP) student and author of this document, to ensure the established project 
goals and timeline are met in accordance with the project plan.  
   In addition to RNs, physicians, and senior executives, involvement and 
participation from other healthcare team members as internal stakeholders is needed.  
These additional team members and internal stakeholders include NPs, PAs, infection 
preventionists (IPs), pharmacists, RTs, quality and safety specialists, nutritionists, and 
other ancillary or support staff.   
Efforts to eliminate HAIs by external stakeholders have further driven 
improvement nationwide.  External stakeholders include CMS, TJC, CDC, professional 
healthcare organizations, hospital associations, and state or national legislators.  
Government agencies and payers have pressured healthcare organizations to reduce HAIs 
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through regulations, payment incentives, or reliance on market forces such as reporting 
high-quality and low-quality providers to consumers (Pronovost et al., 2011).  The 
reduction of CLABSIs will be an integral element in the nationwide HAI reduction 
efforts. 
Organizational Assessment 
 Early in 2006, our healthcare system instituted a focused plan to reduce or 
eliminate four HAIs, one of which was CLABSIs.  The CLABSI rates for the healthcare 
system were above national established and published rates, effecting patient outcomes, 
LOS, and reimbursements.  The evidence-based central line insertion bundle was 
implemented throughout the healthcare system in conjunction with monthly reporting of 
individual hospital bundle implementation achievement.  It was evident during the 
implementation phase that a change in the culture was needed to not only implement the 
evidence-based central line insertion bundle and reduce CLABSI rates, but also to create 
a sustainable model for improvement.   
 Progress in CLABSI rate reduction has continued since the 2006 initial 
implementation of the evidence-based bundle approach.  However, 41 out of our 49 acute 
care hospitals currently have CLABSI rates exceeding the healthcare system internal 
target.  Preventable HAIs are an important focus of governmental agencies, accrediting 
bodies, pay-for-performance proposals, and consumer groups (Sawyer et al., 2010).  Our 
healthcare system recognized that to reduce CLABSIs, the focus would need to be 
consistent compliance with evidence-based practices and improvements in the culture and 
teamwork within the ICUs.  The CUSP framework was selected for implementation in 
our continuing efforts to reduce or eliminate CLASBSs across the healthcare system.  
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Team Selection and Formation 
The foundation for this project is the assembled unit-based team for each 
participating ICU in the project.  The individuals that comprise the unit-based teams are 
responsible for implementing and sustaining the initiative (AHRQ, 2012).  The unit-
based team composition of each participating ICU was required to include, at a 
minimum, a team leader, physician champion, executive champion, and bedside RNs 
from each scheduled shift.  CUSP team member guidelines were developed and are 
presented in Appendix A. 
The recommended project team leader is the ICU Manager/Director.  The project 
team leader serves as the primary contact within the CUSP team who will organize and 
lead the team, articulate the goals of the project, develop decisions using the collective 
input of the CUSP team members, promote and facilitate good teamwork, and promptly 
disseminate information to the CUSP team members (AHRQ, 2012).   
The recommended physician champion is the designated ICU Medical Director or 
the ICU Intensivist.  The physician champion is charged with advancing the project, 
bridging any communication gaps, and securing the buy-in of other physicians to 
participate in the CUSP project (AHRQ, 2012). 
The recommended executive champion for each unit-based ICU team is the 
hospital Chief Nursing Officer (CNO) due to the organizational reporting structure of the 
ICU and the essential connection of quality initiatives and outcomes to the role and 
responsibility of the CNO in each hospital.  The executive champion is the senior leader 
who partners with the CUSP team and takes an active role in the CUSP initiative (AHRQ, 
2012).  The direct link of this senior executive with other hospital executives helps 
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guarantee the initiative is taken seriously hospital-wide and the project remains an 
organizational priority (AHRQ, 2012).  Guidelines to assist CUSP team leaders and 
members in key messaging for executive sponsorship are presented in Appendix B. 
Engaging staff RNs from each shift will provide the frontline expertise and patient 
care knowledge to help sustain the effects and success of the CUSP initiative (AHRQ, 
2012).  Additional members who would be helpful to involve in the unit-based team 
composition include IPs, RTs, pharmacists, quality and safety specialists, and 
nutritionists.  The unit-based focus of the CUSP provides a manageable approach when 
initiating cultural change in an organization (Pronovost et al., 2005).           
Scope of the Project  
 The scope of this project will include the education, training, and implementation 
of the CUSP as a catalyst in the reduction or elimination of CLABSIs in the adult ICUs 
throughout our healthcare system.  The CUSP teams will be developed within the adult 
ICUs of the participating hospitals.  Use of the CUSP will not be applied in any other 
clinical department or QI initiative during the course of this project.  All CVCs used for 
intravenous fluid, medication, dialysis, or administration of TPN to adult ICU patients 
will be included.  The CLABSI definition and standard outcome measure of surveillance, 
as delineated by the CDC, will be utilized for the identification and evaluation of 
CLABSIs throughout the project.        
Effects on the Healthcare System 
 The success of this project will demonstrate that the implementation of the CUSP 
resulted in the project goal of reducing or eliminating CLABSIs in the ICUs within our 
healthcare system.  The national On the CUSP: Stop BSI program integrated methods to 
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translate evidence into practice with safety culture improvement methods and a system 
for measurement of infection data (Sawyer et al., 2010).  This approach illustrates that 
implementation of interventions must be tailored to the local hospital setting where 
patient care is delivered to recognize and resolve potential patient safety hazards or 
untoward outcomes (Sawyer et al., 2010). 
CLABSIs, and associated care complications, lead to increases in morbidity and 
mortality, LOS, and healthcare costs (DePalo et al., 2010).  The estimated costs 
associated with CLABSIs are approximately $45,000 per infection (Lissauer et al., 2012).  
The literature review revealed multiple studies that have resulted in the significant 
reduction of CLABSIs after the implementation of evidence-based strategies inclusive of 
the CUSP.  The RI ICU collaborative study was able to demonstrate the prevention of 42 
CLABSIs reduced ICU LOS by 608 days with cumulative savings of approximately $2M 
(DePalo et al., 2010).  This project will offer a strategy to improve clinical outcomes, 
decrease lengths of stay, and reduce costs of care associated with CLABSIs across our 
healthcare system.   
The need for evidence-based interventions that ultimately improve patient 
outcomes is essential in complex healthcare environments.  The success of the CUSP will 
validate the future use and replication of a systematic approach to undertake other QI 
initiatives throughout our healthcare system.   
Mission, Goals, and Objectives Statements 
Mission  
 The mission of this project is to utilize a nationally recognized program, with 
proven results in reducing CLABSIs, to engage bedside care providers in improving 
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safety processes, communication, and teamwork, with senior leadership support.  Further, 
introducing and educating teams to the CUSP will advance the sustainability of the 
outcome metrics through our quality and safety improvement initiatives.     
Goals 
 The ultimate goal of this project will be to reduce or eliminate CLABSIs across 
our healthcare system.  Additional goals of this project will be to: 
1. Determine the causal effects of the CUSP on the reduction of CLABSIs within 
the participating ICUs 
2. Determine the association of the CUSP team member webinar attendance to 
the reduction in CLASBIs 
Objectives 
 The objectives for this project will be presented and categorized as outcome and 
process objectives.  The outcome objective of this project will be to: 
1. Achieve a 30% reduction in CLABSIs across the healthcare system by the 4th 
quarter of 2013  
The process objectives for this project will be to: 
1. Educate participating ICU teams on the culture of safety and the CUSP 
2. Implement the CUSP in all participating ICUs 
3. Measure and report the number and rate of CLABSIs for each participating 
ICU and system-wide 
4. Enforce the utilization compliance of the bundled evidence-based blood 
stream infection prevention practices in conjunction with the CUSP education  
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CHAPTER III – THEORETICAL UNDERPINNINGS OF THE PROJECT 
Theoretical Framework 
 The use of theoretical frameworks progresses our knowledge of organizational 
factors that are central to successful implementation and sustainment of innovations 
(Jones, Skinner, High, & Reiter-Palmon, 2013).  The theoretical framework used for this 
project is Rogers‟ Diffusion of Innovations (Rogers, 2003).  According to Rogers (2003), 
diffusion is the process in which an innovation is communicated through certain channels 
over time among the members of a social system.  Innovation refers to an idea, practice, 
or object that is perceived as new by an individual or other unit of adoption (Rogers, 
2003).  Newness in an innovation does not just involve new knowledge, but may also be 
expressed in terms of persuasion or a decision to adopt (Rogers, 2003).   
 The evidence-based central line insertion bundle was not new knowledge for our 
healthcare teams, however, the attitudes toward the bundle and the decisions to adopt its 
use into practice on a consistent basis define it as an innovation.  The implementation of 
the CUSP framework as a means to further reduce or eliminate CLABSIs is a new idea or 
innovation for the assembled teams within our healthcare system.       
 Five perceived attributes of innovation diffusion that influence the rate at which 
an innovation is adopted include relative advantage, compatibility, observability, 
complexity, and trialability, and (Rogers, 2003).  The attributes of relative advantage and 
compatibility are especially important in explaining the rate of adoption and diffusion of 
an innovation (Rogers, 2003).  Relative advantage is the degree to which an innovation is 
perceived as being advantageous and compatibility is the degree to which an innovation 
is perceived as being consistent with the values and norms of potential adopters (Rogers, 
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2003).  An innovation that is perceived as advantageous and compatible will be more 
rapidly adopted and diffused.  The relative advantage and compatibility of the CUSP 
program was provided through the team education sessions and was an important part of 
the message content about this innovation to assist in the diffusion process.  Observability 
is the degree to which the results are visible to others (Rogers, 2003).  The extent to 
which potential adopters can observe the adoption of an innovation by others can 
determine its success for diffusion (Rogers, 2003).  The observability of the CUSP was  
accomplished through peer testimonials and national success examples provided by the 
program participants during the education sessions.  Complexity is the degree to which an 
innovation is perceived as difficult to understand and use (Rogers, 2003).  It was essential 
to equip the CUSP team members with a thorough understanding of the CUSP to 
facilitate the adoption of the innovation.  Trialability is the degree to which an innovation 
can be used prior to adoption (Rogers, 2003).  The CUSP team members were provided 
opportunities to use the skills and tools acquired throughout the education sessions.  
 Individuals and groups do not all adopt an innovation at the same time (Rogers, 
2003).  The adoption within individuals and groups typically follows a normal 
distribution which can be described with five adopter categories that assist to explain 
variation in adoption:  innovators, early adopters, early majority, late majority, and 
laggards (Rogers, 2003).  These adopter categories are the classifications of individuals 
and groups on the basis of their innovativeness, the degree to which an individual or other 
unit of adoption is relatively earlier in adopting new ideas than other members of a group 
or system (Rogers, 2003).  It was important for the project leader and the CUSP team 
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leaders to recognize that the assembled teams are composed of an array of individuals 
who may differ in their progression and patterns of innovation adoption.                   
 The decision to adopt or reject an innovation is conceptualized in several stages 
that occur over time.  The Diffusion of Innovations theory proposes that knowledge, 
persuasion, decision, implementation, and confirmation are the five stages in the 
innovation-decision process (Rogers, 2003).  This process is one that individuals and 
other decision makers go through as they move from gaining initial knowledge about an 
innovation, form their attitude about the innovation, make a decision to adopt or reject the 
innovation, implement the new idea, and confirm their decision (Rogers, 2003).  The 
innovation-decision process explains the individual psychological processes involved 
with the change experience and the adoption of an innovation (Rogers, 2003).  The model 
of five stages in the innovation-decision process is presented in Figure 5 in the 
Appendices.  The theoretical generalizations of the innovation-decision process integrate 
well with the CUSP framework.  Partnership with senior hospital leaders and the ICU 
teams will help ensure all stakeholders are involved in the change process.  Teams were 
mentored and educated on methods to facilitate change at the unit level, inclusive of 
identifying common barriers, using theoretical and evidence-based strategies.    
Diffusion of an innovation is an uncertainty reduction process (Rogers, 2003).  As 
individuals and other decision makers pass through the innovation-decision process, they 
seek information to decrease the amount of uncertainty they may have about an 
innovation (Rogers, 2003).  Introduction and overview of this initiative, with the specific 
objectives and interventions, assisted in providing knowledge and diminished the 
uncertainty that may have surrounded this innovation.  As uncertainty decreases, the 
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decision to adopt an innovation increases (Rogers, 2003).  The role of this author was as 
facilitator for the assembled CUSP teams and for the innovation diffusion process.   
Rogers‟ Diffusion of Innovations theory provided the change management 
theoretical framework to facilitate the diffusion and adoption of the CUSP in the 
participating ICUs within our healthcare system.  The linkage of the perceived innovation 
attributes and the innovation-decision process stages of the Diffusion of Innovations to 
the CUSP five sequential steps are presented in Table 3 in the Appendices.   
Program Framework  
 The CUSP is a safety culture program that is designed to educate and improve 
awareness about patient safety and quality of care, empower staff to take charge and 
improve safety in their local workplace units, create partnerships between senior 
executive hospital leaders and units to improve organizational culture and provide 
resources for unit improvement efforts, and provide tools to investigate and learn from 
defects (AHRQ, 2011).  The program integrates teamwork, communication, and 
leadership to create and support a culture of patient safety.  The program employs a 
collaborative model in which the key participants are interdisciplinary teams of 
healthcare professionals from units or departments within a hospital (Pronovost et al., 
2011).  The CUSP is implemented and managed at the unit level and involves frontline 
patient care providers who recognize and attempt to prevent patient safety hazards 
(AHRQ, 2011).  The CUSP is comprised of five steps and is designed to integrate an 
evidence-based patient safety structured process into a unit or department (AHRQ, 2011).   
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The five steps of the CUSP are (AHRQ, 2011): 
 Step 1:  Educate on the science of safety 
o This education emphasizes the basic principles of safe design, the 
understanding that safety is part of the work system, and that teams 
make prudent decisions with diverse and independent input. 
 Step 2:  Identify defects/patient safety hazards 
o The CUSP teams were directed to identify, prioritize, and eliminate 
patient safety hazards in their ICUs.  The CUSP teams were asked how 
the next patient will be harmed in their units and how the harm could 
be prevented.  The CUSP team members were empowered with the 
ability to stop procedures if patient safety is compromised.     
 Step 3:  Partner senior executive with unit 
o The senior executive partner reviews the identified patient safety 
hazards and ensures the CUSP teams have the resources and support to 
implement safety risk reductions and assigns accountability to the 
teams to mitigate the hazards. 
 Step 4:  Learn from defects  
o The CUSP teams were requested to use a tool to learn from one defect 
per month that prompts users to answer what happened, why did it 
happen, what was done to reduce risk, and whether the intervention 
reduced the risk.  
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 Step 5:  Implement teamwork and communication tools 
o The CUSP teams were provided several tools which are mechanisms of 
change that can be utilized to improve communication and teamwork 
deficits within their ICUs.  Examples of the communication and 
teamwork tools include the morning briefing, daily goals checklist, and 
shadowing. 
These five sequential steps outline the progression in which the ICUs can assess, 
improve, and evaluate their cultures of safety in efforts to reduce or eliminate CLABSIs.  
The CUSP is the program framework upon which this project was based. 
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CHAPTER IV – PROJECT AND EVALUATION PLAN 
Project Plan 
CUSP Project Overview 
 Our healthcare system entered into a partnership agreement with the Center for 
Patient Safety for the provision of the CUSP training, education, and support for the ICUs 
participating in this project within our healthcare system.  The CUSP is a structured 
strategic framework for safety improvement that integrates communication, teamwork, 
and leadership to create and support a culture of patient safety that can prevent harms 
(AHRQ, 2011).  The program features evidence-based safety practices, staff training 
tools, standards for consistently measuring infection rates, engagement of leadership, and 
tools to improve teamwork among physician, nurses, and other direct care providers in 
the ICUs (AHRQ, 2011).   
   The program is a six-month course, offered through a series of six consecutive 
monthly webinars and teleconferences, designed to assist hospitals in implementing the 
CUSP to ICU teams for success in the reduction of CLABSIs.  The course guides 
participants through the process of creating a unit or department-based CUSP team, 
evaluating the patient safety culture, educating staff on the science of safety, and 
identifying and solving defects.  Each step of the CUSP builds on the previous work to 
systematically provide frontline patient care providers with the tools, metrics, and 
framework to undertake the challenge of QI.  The content description and objectives for 
each of the six monthly sessions are outlined in Appendix C.     
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Setting 
 The project will occur in adult ICUs within our healthcare system.  This 
healthcare system is one of the largest investor-owned healthcare delivery systems in the 
nation.  The healthcare system is comprised of 49 acute care hospitals and over 100 
outpatient centers spanning 10 states, employing 57,000 people inclusive of 17,000 
Registered Nurses (RNs).  The acute care division of this healthcare system includes 
hospitals that are critical access, community-based, academic teaching, and large urban 
medical centers.  All hospitals within the healthcare system were invited to participate in 
this initiative.  Forty-one hospitals assembled ICU teams to participate in the education, 
training, and implementation of the CUSP.  The hospitals not participating in this project 
have previously implemented the CUSP or are involved in state level Hospital 
Engagement Networks (HENs) that address efforts to reduce CLABSIs.      
Population of Interest 
 The population of interest identified in this project includes registered nurses 
(RNs), physicians, and other healthcare team members who provide direct care to adult 
ICU patients with CVCs.  The other healthcare team members identified who provide 
direct care to adult ICU patients include NPs, PAs, RTs, and NTs.  Additional healthcare 
team members included in the population of interest who participate in the care of adult 
ICU patients are pharmacists, IPs, nutritionists, and quality and safety specialists.  The 
patient population identified in this project includes all adult patients with a CVC in the 
ICU.   
The corporate clinical operations executives of our healthcare system elected to 
exclude patients admitted to a Pediatric Intensive Care Unit (PICU), Neonatal Intensive 
 27
  
Care Unit (NICU), or any other clinical department outside of the adult ICUs to mitigate 
confounding from multiple settings.  This decision was also in congruence with the 
model established for the numerous collaborative cohort studies conducted to reduce 
CLABSIs.      
Measures, Instruments, and Activities 
 Checklists are cognitive tools that standardize process elements to facilitate care 
delivery, reduce variability, and improve the translation of information among varying 
team members (Winters et al., 2009).  One strategy adopted by the ICUs within our 
healthcare system was the use of a central line insertion care team checklist to ensure 
adherence to evidence-based bloodstream infection prevention practices during CVC 
insertion (Appendix D).  This checklist utilizes the static sequential with verification 
format which involves a challenge and response (Winters et al., 2009).  A designated 
person reads the items on the checklist and each responsible party verifies the completion 
of their specific task (Winters et al., 2009).  This type of checklist helps to reduce 
complexity, create independent redundancies, and ensure the entire team and patients are 
certain about expected behaviors (Sawyer et al., 2010).  Major components of the central 
line insertion care team checklist include four of the five evidence-based bloodstream 
infection prevention practices of handwashing, using full barrier precautions, cleaning the 
skin with chlorhexidine, and avoiding the femoral site when feasible (Pronovost et al., 
2010).  The fifth practice of removing unnecessary catheters is not incorporated into the 
checklist for central line insertion as it focuses on optimizing CVC maintenance.  The 
four evidence-based bloodstream infection prevention practices in the checklist have been 
validated by a detailed practice guideline issued by the CDC and categorized on the basis 
 28
  
of existing scientific data, theoretical rationale, and applicability (O‟Grady et al., 2011).  
These components were also validated in the 2006 seminal Keystone ICU project 
collaborative cohort study where use resulted in a 66% decrease in CLABSI rates 
(Pronovost et al., 2006).    
 Surveillance standardization is essential within and across all of the participating 
adult ICUs to measure the magnitude or impact of prevention strategies on CLABSI rates 
(Worth et al., 2009).  Standardization should incorporate the data collection technique, 
the application of an accepted and valid case definition, and the method of analyzing and 
reporting CLABSI rates (Worth & McLaws, 2012).  The most prevalent data collection 
technique is in accordance with the National Healthcare Safety Network (NHSN) 
methodology (Dudeck et al., 2011).  The validity and reproducibility of the NHSN 
surveillance methodology has been evaluated and is extensively applied within and 
outside the United States (Dudeck et al., 2011).     
Timeline and Project Tasks 
 The timeline for this project will extend from January 2013 through March 2014.  
A detailed timeline with associated tasks for the entire project is presented in Table 4 of 
the Appendices. 
Risks and Threats 
 The identified risks and threats for this project were minimal.  The first identified 
risk of this project was team member attendance and participation in the six monthly 
CUSP webinars and teleconferences.  The six-month webinar schedule with dates, times, 
and access information was distributed to all identified team members prior to the 
initiation of the webinars.  In addition, each webinar was recorded and stored in an 
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accessible electronic folder for subsequent replay in the event a team member missed a 
scheduled session. 
 The second identified risk of this project was team communication and 
collaboration.  Frontline staff, especially RNs, are apprehensive about identifying 
potentially hazardous situations for fear of repercussion or other barriers (Southworth, 
Henman, Kinder, & Sell, 2012).  One advantage of the CUSP is its empowerment of 
frontline staff to assume responsibility for patient safety by generating issues, prioritizing 
them, and implementing them based upon the ICU identified needs (Pronovost et al., 
2005).  Enhanced autonomy and communication by RNs alters role expectations of both 
nurses and physicians (Southworth et al., 2012).  This risk was mitigated through the 
provision of the science of safety education which provides a conceptual framework and 
a common safety vocabulary that allows frontline staff to recognize, surface, and address 
defects at the unit level (Southworth et al., 2012).   
Evaluation Plan 
 The impact of the CUSP on the reduction or elimination of CLABSIs was 
evaluated using a pre-and post-implementation comparison of hospital CLABSI rates.  
This outcome measure was selected because the CDC provides a standardized definition 
of CLABSIs and all of the hospitals within our healthcare system currently collect and 
report this data.  This standard outcome measure for surveillance is defined as the number 
of CLABSIs per 1,000 central line catheter days, where the numerator is the number of 
CLABSIs and the denominator is the number of catheter days (O‟Grady et al., 2011).  
Data for the numerator and denominator was collected by the IPs at each participating 
hospital, independent of the established ICU CUSP teams.  Evaluation of the project 
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through data collection of CLABSI rates offers accountability to the stakeholders, 
demonstrates improvement in quality and outcomes, and provides rationality to the 
initiative (Zaccagnini & White, 2011).   
 Baseline performance was measured using the September 2012 through January 
2013 CLABSI rate data for our healthcare system.  Baseline performance must be 
measured to understand the improvement opportunity and the magnitude of improvement 
after implementation of the CUSP (Pronovost, Berenholtz, & Needham, 2008).  
Throughout the project, the CUSP teams received monthly feedback on the number of 
CLABSIs in the ICUs and quarterly feedback on the CLASBI rates.  Frequent monitoring 
of outcomes and feedback to the CUSP teams can have a significant impact on the 
confirmation stage of the innovation-decision process.  During the confirmation stage, 
individuals seek to reinforce the innovation adoption decision previously made through 
the validation of its impact (Rogers, 2003).  The CUSP team training and education was 
completed at the end of July 2013.  Analysis of the CLABSI rates for August 2013 
through December 2013, with comparison to the baseline period of September 2012 
through January 2013, will be used to evaluate the effect and success of the project.  
Evaluation of the CUSP implementation success through the reduction or elimination of 
CLABSIs will provide an opportunity to determine future use and replication in other 
clinical units and QI initiatives.  
Financial Plan 
 The costs and professional fees for the delivery of the CUSP training, education, 
and support from the Center for Patient Safety will be managed through the funding 
provision of the healthcare system corporate offices.  Materials for the training sessions 
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and webinars will be maintained electronically on the healthcare system intranet share 
point site with access for all participating hospitals.  Additional expenses for the 
participating hospitals in the project will not be incurred.  No funding will be necessary 
for program evaluation completion.          
Institutional Review Board (IRB) 
 This project includes an education and training program designed for the RNs, 
physicians, and other previously identified healthcare team members within our 
healthcare system ICUs.  This project is a QI initiative without the use of human subjects.  
Data used will be de-identified and reported in the aggregate.  Because of this project 
design, IRB approval is not required.  The Biomedical IRB Notice of Excluded Activity 
from the University of Nevada, Las Vegas (UNLV) Office of Research Integrity-Human 
Subjects is presented in Appendix E. 
Maintaining/Sustaining the Change 
 Sustained reduction or elimination of CLABSIs will require continued efforts.  
The seminal Keystone ICU Project demonstrated that the reduction of CLABSIs can be 
sustained with ongoing focus and monitoring efforts (Pronovost et al., 2006).  The 
durability of this effect suggests that not only can behaviors be changed, but education, 
engagement, monitoring, and feedback can sustain these gains beyond the intervention 
stage (AHRQ, 2013).  Increased understanding of the root causes of CLABSIs that do 
occur will provide valuable insights that will sustain improvements long term (Clancy, 
2012).       
 To sustain our efforts, the hospitals within our healthcare system will be requested 
to formally integrate and incorporate the CUSP into their QI plans and efforts.  This will 
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include ongoing measurement and feedback of performance, encouragement of the teams 
to continue the work, and incorporating the CUSP education into staff orientation.  In 
addition, plans will be formulated to integrate the CUSP into other clinical areas outside 
of the ICUs where CVCs are also inserted.    
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CHAPTER V – SUMMARY OF IMPLEMENTATION AND RESULTS 
Initiation of the Project 
 The project was initiated in January 2013 under the direction of the DNP student 
and author of this document.  All hospitals within our healthcare system with ICUs for 
adults were invited to participate in this project.  Correspondence was sent to all Chief 
Executive Officers (CEOs), CNOs, Quality Directors (QDs), IPs, and Risk Managers 
(RMs) with an overview of the CLABSI CUSP project organization, project objectives, 
and the dates and times for each of the six consecutive monthly webinars.  Hospital 
CUSP team membership guidelines were distributed to the CNOs for assignment, 
completion, and return.  A share point site was created on the healthcare system intranet 
as the repository for all CUSP education and training materials.  Access to this share 
point site was provided for all participating hospitals and CUSP team members.  
Communication, coordination, and completion of these items were essential to ensure a 
smooth transition into the educational intervention. 
      Education of the identified hospital CUSP team members was accomplished 
through a series of six consecutive monthly webinars and teleconferences beginning on 
February 26, 2013 and culminating on July 23, 2013.  The webinars were approximately 
one hour in duration and focused on an introductory overview of the entire program and 
each of the five steps of the CUSP.  The format of the webinars included a power point 
presentation on one specific component or step of the CUSP program followed by a 
question-and-answer period with the teams.  Technical support and clinical guidance 
were offered through each of the webinars and teleconferences.  In addition to the 
didactic content of each webinar, hospital CUSP team members were encouraged to 
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participate by sharing their successes and challenges to expand their knowledge as they 
evolved with implementation of the program.  The webinars were designed to prepare the 
teams to implement the CUSP and develop a social network of hospitals and colleagues 
that learn together during implementation (Della et al., 2012).  The creation of this social 
community enabled the CUSP team members across all hospitals to mutually reinforce 
beliefs about the importance of preventing CLABSIs and fostered synergistic 
improvements to reduce these infections (Pronovost et al., 2011).  
 Providing resources, tools, and support for the CUSP teams to ensure innovation 
adoption throughout the course of the project was imperative to effective program 
implementation and achieving project objectives.  Additional resources and support were 
provided for the CUSP team leaders that included team ground rules, team meeting 
agendas inclusive of content items for the meeting and facilitation guidance instructions 
for the team leaders, staff safety assessment form, attendance sheet for staff safety 
training and assessment completion, and the learn from defects tool worksheet.  These 
documents are provided in the Appendices labeled Appendix F through Appendix O.      
Threats and Barriers to the Project 
 Common barriers to implementation of best practices to reduce or eliminate 
CLABSIs include lack of leadership support, lack of a safety culture, and inadequate 
education (Kusek, 2012).  Leadership support was not an identified barrier in this project.  
Education of the CUSP teams was also not an identified barrier because of the designed 
instructional intervention that addressed the overview of CUSP and the five sequential 
steps of the program.  The CUSP is designed to improve the safety culture of a unit 
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through increasing awareness of quality care problems and encouraging communication 
and teamwork (Lin et al., 2012).   
Although these common barriers were not identified in this project, several 
hospitals experienced early challenges with the CUSP implementation and the spread of 
change throughout the units and to the clinicians.  Engaging frontline physicians was an 
early identified barrier in the project.  This challenge did not significantly delay the 
project progress and was addressed individually by the CUSP team physician and 
executive champions.  Nursing empowerment, a documented advantage of the CUSP, 
was also an identified early challenge.  Nursing staff reluctance to question or challenge 
physicians and other healthcare team members when they observed noncompliant patient 
care delivery posed a potential obstacle to achieving the desired outcomes associated with 
the CUSP.  This risk was mitigated through consistent, supportive leadership 
involvement and reinforced by physician, nurse, and executive champions that assisted in 
eliminating any dissent and contributed to program success.  Teams discovered that safe 
dialogue was essential to foster trust, transparency, and program commitment (Lin et al., 
2012).  
 These identified cultural barriers must be considered and addressed when 
attempting to improve the quality and reliability of patient care.  An effective 
methodology that was employed to assist the teams to address local barriers and impact 
change was a “four Es” approach:  (1) engage staff in the need to address the problem 
and why the interventions are important; (2) educate staff on the evidence supporting the 
interventions; (3) execute the intervention activities and practices targeted at the barriers 
and challenges; and (4) evaluate the process and outcomes regularly (Pronovost, 
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Berenholtz, & Needham, 2008).  This approach recognizes the importance of culture 
change, contextual factors, engaging staff in the project, and identifying local barriers.  
As such, this approach complimented and aligned with the overall framework of the 
CUSP and provided structural guidance for the teams to assist in addressing and 
overcoming associated project barriers.      
Monitoring of the Project 
 Monitoring of the project implementation and ongoing efforts to measure progress 
against the goals and objectives, mission statement, evaluation plan, and timeline was an 
important task.  Maintaining the momentum of this large-scope project was an essential 
element in achieving the desired goals and outcomes.  The project required that all of the 
team members and stakeholders collaborate, understand the basis of the work and the 
sequential progression of the project, and complete the required program tasks.  Because 
of the sequential nature of the webinars and associated project assignments, it was 
imperative to ensure that the CUSP teams progressed collectively and completed the 
required actions in the established time frames.  Checklists were developed and provided 
to each CUSP team leader that outlined the specific actions required of the team for each 
of the six webinars and the associated resources to assist in the completion of each action 
item.  The six checklists are provided as tables in the Appendices labeled Table 5 through 
Table10.  The actions listed on each checklist were required to be completed by each 
CUSP team prior to the next scheduled webinar.   
Variation in adoption and completion of the actions required of the CUSP team 
members following each consecutive webinar can be associated with the Diffusion of 
Innovations framework that describes the five adopter categories of innovators, early 
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adopters, early majority, late majority, and laggards (Rogers, 2003).  Individual guidance, 
support, assistance, and consultation was provided throughout the project for the hospital 
CUSP teams, as requested by the CUSP team leader or observed by the project leader, to 
facilitate movement through the organizational stages of innovation and complete the 
associated program requirements in accordance with the project scope and timeline.   
Data Collection 
 Throughout the project, data on the number of CLABSIs was collected monthly 
by the hospital–based IP in accordance with the NHSN methodology and definition of 
CLABSIs (Dudeck et al., 2011).  Hospital CUSP teams received monthly feedback on the 
number of infections and quarterly feedback on the rate of infections per 1,000 catheter 
days.  The feedback of data to teams is critical in generating peer pressure for change and 
compliance and to ensure that continual modification and evaluation of processes have 
achieved the desired result (McMullan et al, 2013).  One attribute of the Diffusion of 
Innovations theory is relative advantage, the degree to which an innovation is perceived 
as being advantageous (Rogers, 2003).  Timely and frequent feedback on the number and 
rate of infections to the team members was a method to demonstrate relative advantage to 
assist in the adoption and diffusion of this innovation.      
 CUSP team member attendance for each of the webinars was tracked by the team 
leaders on a webinar attendance form (Appendix P) and submitted to the project leader at 
the end of the final webinar in July 2013.  Attendance records were utilized to determine 
the association between the CUSP webinar attendance and reduced CLABSI rates.  
Although the webinars were recorded for playback at a later time, attendance was 
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determined based upon documented presence at the webinar on the CUSP team webinar 
attendance form, due to the interactive nature and design of the presentations.       
Data Analysis 
 Data was analyzed using the Statistical Analysis Software (SAS) version 9.20 and 
Medcalc version 13.0.4.0.  Data comparing the months of September 2012 to January 
2013 (baseline pre-CUSP implementation) to data from August 2013 to December 2013 
(post-CUSP implementation) was analyzed.  These time periods were selected to allow 
for assessment of the largest sample and to correlate with the pre-and post-CUSP 
implementation periods.   
Inferential statistical analysis was used in the examination of the data.  The 
CLABSI rates per hospital were calculated as the average of the CLABSI rates from the 
ICUs in the hospital which gives each ICU the same weight and provides information 
regarding CLABSI rate reduction for an average ICU in the project.  A Poisson 
distribution was used to examine the relationship between time since the CUSP 
implementation and CLABSI rates.  The Poisson analysis was also used to generate an 
incidence rate ratio (IRR) to compare pre-and post-CUSP implementation CLABSI rates, 
as had been done in previous studies (O‟Grady et al., 2011; Pronovost et al., 2006).  
Analysis of infection statistics often employs Poisson distribution on the assumption that 
infections occur independently and at random in populations.  The Pearson product-
moment correlation coefficient I and the coefficient of determination (r
2
) were used to 
explore the association between the pre-and post-CUSP implementation CLABSI rates 
and the relationship of CLASBI rate reduction and webinar attendance.  All reported P 
values of 0.05 or less were considered to indicate statistical significance.   
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Giving Meaning to the Data 
Results 
 Data are reported for 65 ICUs, representing 41 hospitals and 113,288 catheter 
days across the baseline pre- and post-CUSP implementation time periods.  The total 
number of CLABSIs reported for the baseline pre-CUSP implementation time period of 
September 2012 to January 2013 was 71, with an infection rate of 1.10 per 1,000 catheter 
days.  The data for the post-CUSP implementation time period of August 2013 to 
December 2013 revealed a decrease in the total number of CLABSIs to 42, and a 
resultant decrease in the infection rate to 0.73 per 1,000 catheter days.  This decrease 
represented a 32.8% reduction in CLASBIs post-CUSP implementation.  As shown in 
Table 1, Poisson 95% confidence intervals were calculated to determine the statistical 
significance between the pre-and post-implementation CLABSI rates.  The P value of 
0.0398 demonstrates a statistical significance was observed between the pre-and post-
CUSP implementation CLABSI rates.   
Pre-CUSP Incidence Rate 1.1005 
   95% Confidence Interval 0.8595 to 1.3882 
Post-CUSP Incidence Rate 0.7394 
   95% Confidence Interval 0.5329 to 0.9995 
Incidence Rate Difference 0.3611 
   95% Confidence Interval 0.0169 to 0.7053 
   P-value P = 0.0398 
Incidence Rate Ratio 1.4883 
   95% Confidence Interval 1.0023 to 2.2347 
 Table 1.  CLABSI Rate Comparison Pre-and Post-  
     CUSP Implementation  
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Poisson 95% confidence intervals were also calculated for differences between the pre-
CUSP and post-CUSP implementation CLABSI rates for each participating hospital.  
Table 11 demonstrates the results of this analysis which is located in the Appendices.     
 The Pearson product-moment correlation coefficient I and the coefficient of 
determination (r
2) was calculated to compare each hospital‟s rates with their own rates to 
determine if an association existed between the pre-and post-CUSP implementation 
CLABSI rates.  The Pearson r = 0.131 and r
2
 = 0.0174 demonstrated a weak positive 
linear relationship between these two rates (Figure 1).  Only 1.74% of total variation in 
post-CUSP implementation CLABSI rates can be explained or accounted for by variation 
in the pre-CUSP implementation CLABSI rates. The P value was 0.414 which indicates 
there was not a statistical significance in the correlation of these rates.  
 
Figure 1.  Individual Hospital CLABSI Rate Comparison Pre-and Post-CUSP 
      Implementation    
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The control chart in Figure 2 displays the trend in CLABSI rates from the 1
st
 
Quarter in 2012 through the 4
th
 Quarter in 2013.  Prior to the 1
st
 Quarter in 2013, an 
upward trend in CLABSI rates was observed that had prompted the need for this project.  
A significant decline in CLABSI rates was observed in the 1
st
 Quarter of 2013 coincident 
with the initiation of the CUSP project.  A slight increase in CLABSI rates was observed 
in the 2
nd
 Quarter of 2013 which was not validated with any particular findings.  
Subsequent decreases in CLABSI rates were observed in the last two quarters of 2013 
post-CUSP implementation.   
 
 
 
 
 
 
 
 
 
 
 
Figure 2.   CLABSI Rates Trended Comparison 1
st
 Q 2012 – 4th Q 2013 
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The Pearson product-moment correlation coefficient I and the coefficient of 
determination (r
2
) was calculated for each hospital, based on CUSP team webinar 
attendance forms, to determine the strength of the association between overall webinar 
attendance and post-CUSP implementation CLABSI rates.  Attendance for each webinar 
was calculated based on required attendees and actual attendees.  The Pearson r = 0.06 
and r
2
 = 0.0041 demonstrated a weak positive linear relationship between these two rates 
(Figure 3).  The P value of 0.701 indicated there was not a statistical significance that was 
demonstrated in this statistical analysis associated with webinar attendance and CLABSI 
rate reduction. 
 
Figure 3.  Overall Webinar Attendance and Post-CUSP Implementation  
                 CLABSI Rates  
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attendance was defined as the 25
th
-75
th
 percentile, and poor attendance was defined as ≤ 
the 25
th
 percentile (Figure 4). 
 
Figure 4.  Webinar Attendance by Category 
The CLABSI rates between attendance categories were compared to evaluate if being a 
part of one of these categories correlated with infection rate reductions.  Pre-and post-
CUSP implementation CLABSI rates were compared based upon the three determined 
attendance categories.  The data displayed in Table 2 demonstrated significant reductions 
in CLABSI rates post-CUSP implementation for webinar attendance in the fair and good 
categories.   
  Attendance 
Category 
Pre-CUSP 
Implementation 
Period 
CLABSI Rate 
per 1000 
Catheter Days 
Post-CUSP 
Implementation 
Period 
CLABSI Rate 
per 1000 
Catheter Days 
P Value % Reduction 
Poor 1.543 
(27/17491) 
1.520 
(24/15783) 
0.957 1.4% 
Fair 0.479 
(15/31300) 
0.154 
(4/25879) 
0.034 67.7% 
Good 1.896 
(22/11603) 
0.890 
(10/11232) 
0.042 53.0% 
Table 2.  Comparison of Pre-and Post-CUSP Implementation Rates by Attendance                
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This CLABSI rate reduction was statistically significant in both the fair and good 
webinar attendance categories with P values at 0.034 and 0.042 respectively.  There was 
no significant CLABSI rate reduction observed in the hospitals categorized with poor 
attendance and the percent reduction was low.  Poisson 95% confidence levels were also 
calculated to determine the differences in the webinar attendance and pre-and post-CUSP 
CLABSI rate reductions and to determine statistical significance between the two rates.  
These results also revealed statistical significance for webinar attendance and CLABSI 
rate reduction in the fair and good attendance categories and no significant CLABSI rate 
reduction in the poor attendance category.  The detailed results of this analysis are 
located in Table 12 in the Appendices.              
Discussion 
 CLABSIs are a significant cause of preventable harm that lead to increases in 
morbidity and mortality, length of stay, and healthcare costs (Hong, et al., 2013).  At the 
onset, our healthcare system sought to evaluate whether an improvement in culture, 
through the implementation of the CUSP, could result in achieving the established goal of 
a 30% reduction in CLABSIs across the participating hospitals in the system.  
Comparison of pre-and post-CUSP implementation CLABSI rates revealed a 32.8% 
reduction that exceeded the overall project goal, demonstrated a causal association of the 
CUSP implementation and the reduced CLABSI rates, and confirmed that a large-scale 
project focused on reducing CLABSIs is feasible.  There were a total of 25 out of the 41 
hospitals (61%) that achieved a CLABSI rate of zero in the post-CUSP implementation 
period.  However, 12 of the 41 hospitals (29%) had an established CLABSI rate of zero 
pre-CUSP implementation.  Nonetheless, 13 additional hospitals reported CLABSI rates 
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of zero post-CUSP implementation which resulted in doubling the number of hospitals 
reporting zero infections by the end of the project.  This study demonstrates that 
CLABSIs are preventable in ICUs and supports recent studies which suggest that up to 
90% of CLABSIs may be preventable (Pronovost et al., 2010). 
 The interactive design of the webinars that allowed the CUSP team members 
across our healthcare system to share successes and challenges established collaboration, 
trust, and enhanced teamwork.  Two attributes of the Diffusion of Innovations theory are 
observability, the ability to observe the adoption of an innovation by others, and 
trialability, the ability to experiment (Rogers, 2003).  The CUSP teams established a 
network where those who had successes were able to share their experiences on what 
worked for them, how they achieved the success, and how they adapted the framework to 
work within their culture and hospital.  Implementation of the CUSP relies on local 
accountability and ownership to adopt and adapt this innovation into daily work practices 
(Marsteller et al., 2012).  As predicted by the Diffusion of Innovations theory, this 
interpersonal network assisted in overcoming any barriers in the process of the CUSP 
implementation and enhanced the adoption and diffusion of the innovation.               
Study Limitations 
 This study had several limitations.  First, we did not separate the efforts intended 
to directly improve culture, through the implementation of the CUSP, and the other 
prevention strategies and technologies to reduce CLABSIs such as increased compliance 
with the central line insertion bundles, physician insertion technique changes, post-
insertion maintenance care practice changes, or the use of impregnated dressings or 
catheters and chlorhexidine baths.  Nevertheless, the CUSP was the main intervention 
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used by the teams and improvements in unit culture and clinical outcomes intersected.  
Second, organizational and staffing challenges, such as changes in team leadership or 
executive sponsors, were not considered in the continued CUSP implementation of the 
individual impacted hospitals.  These changes are common, often unanticipated, and have 
the potential to slow the rate of diffusion with the other team members and the hospital.  
The adoption of an innovation by individuals in an organization is more likely if key 
individuals are present and willing to support the innovation (Rogers, 2003).  Committed 
team leadership and visible executive leadership have been demonstrated as key 
contributing factors in the success of the CUSP (Koll et al., 2008).  Third, participation in 
the CUSP to reduce CLASBIs was not a mandated directive from the executives in our 
healthcare system.  Although we had an 84% hospital participation rate in the project, a 
mandatory directive would have provided the CUSP education for the other non-
participating hospitals which could have been utilized in the spread of this methodology 
to other QI initiatives within their organizations.  The CUSP has been demonstrated for 
application to reduce other types of preventable harm (Pronovost et al., 2011).  Fourth, 
we did not measure or have a mechanism to determine if team members unable to attend 
the live educational webinars went back and reviewed the recorded sessions at a later 
time frame.  Although not interactive, the translation of knowledge from the webinar 
could have been disseminated to these team members.  A methodology to gather this 
information for future similar initiatives and projects may prove to be beneficial in 
determining the impact of education and overall attendance rates.  Fifth, hospital size, 
complexity of services, patient acuities, and comorbidities were not analyzed as potential 
contributing factors impacting the amount and rate of CLABSI reductions associated with 
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the CUSP implementation.  Understanding patients who are more at risk for CLABSIs 
may allow targeted efforts at prevention and early diagnosis in the highest risk groups 
(Lissauer et al., 2012).  Finally, we did not collect data for ICU mortality, length of stay, 
and costs of care, which limits the ability to determine whether the resulting 
improvements in CLABSI rate reductions led to reductions in these outcomes as well.       
Conclusion 
 Although multifaceted interventions to reduce the incidence of CLABSIs have 
been demonstrated to be successful, CLABSIs continue to be identified (Lissauer et al., 
2012).  The pioneering work of Pronovost and colleagues at Johns Hopkins Hospital and 
the consortium of Michigan hospitals, as well as other efforts across the United States, 
have confirmed that the effective application of evidence-based practices can have a 
profound effect on the incidence of CLABSIs (AHRQ, 2012).  This project demonstrated 
that an uncomplicated, inexpensive, evidence-based educational intervention, the CUSP, 
resulted in a 32.8% reduction in CLABSI rates.  Evidence-based educational 
programmatic interventions have proven effective in reducing CLASBI rates (Parra et al., 
2010).  The progress achieved with this project challenges the difficulty of changing the 
culture and practice of medical and nursing staff, which takes time and perseverance.  
Programs to improve quality of care must address culture (Pronovost et al., 2011).  In this 
program implementation, addressing culture occurred at three levels:  (1) recognition that 
each hospital and ICU are microsystems within which an intervention is implemented; (2) 
enlistment of senior leaders to ensure support of the efforts to reduce CLABSIs; and (3) 
the creation of a social community within our healthcare system which has helped to 
create innovative standards regarding CLABSIs. 
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 A leading item on the research agenda for QI initiatives is identifying methods 
that sustain a successful project (Pronovost et al., 2010).  Sustainability is making an 
innovation routine, is often ambiguous, and may not always be legitimately separated 
from the initial implementation and evaluation of the project (Greenlaugh, Robert, 
MacFarlane, Bate, & Kyriakidou, 2004).  However, sustainability should be examined 
separately from implementation.  Continued success in this endeavor will require ongoing 
attention, commitment, support, monitoring, and collaboration.  The progress achieved in 
this project with the reduction in CLABSI rates highlights the preventability of these 
infections and provides the framework that can be successfully applied to other QI 
initiatives.  
Dissemination and Utilization of Results 
 The initial findings from this project were presented to our healthcare system 
corporate QI Council on February 18, 2014.  In addition, each hospital was provided with 
their individual findings and results from participation in the project.  As a result of the 
demonstrated success and initial results from this project, our healthcare system has 
decided to launch the CUSP program initiative again with an emphasis on catheter-
associated urinary tract infections (CAUTIs).  The complete findings and results from 
this project will be provided in webinar presentations for the healthcare system in the 
second quarter of this year.  The DNP student and author of this document will plan on 
pursuing publishing the project later this year in a peer-reviewed journal.       
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Appendix A 
CUSP Team Membership Guidelines 
 
 Members of a CUSP team will vary by unit and by focus of the CUSP initiative  
 
 A general rule is to have representation from all types of staff members who provide 
direct patient care on a unit.  
 
 At a minimum, the following staff should be on your CUSP team: 
1. Team Leader 
 Ideally should be a CNS (advanced practice), Unit Nurse 
Manager/Director, Unit-based Quality Nurse,  or Nurse Educator 
 Should have leadership skills, including project management and 
communication abilities 
 Anticipated Time Commitment:  4-5 hours per month (1 hour of coaching 
calls, 2 hours of planning, 1-2 hours of team meetings) 
2. Physician Champion 
 Anticipated Time Commitment:  3-4 hours per month (1 hour of coaching 
calls, 1 hour of planning with Team Leader, 1-2 hours of team meetings) 
3. Executive Champion 
 Anticipated Time Commitment:  1-2 hours per month (1-2 hours of team 
meetings) 
 See Appendix B – Key Messages for Senior Leaders – for messages to 
assist in the recruitment an executive champion 
4. Staff Nurse (from each shift) 
 Anticipated Time Commitment:  1.5-2.5 hours per month (1-2 hours of 
team meetings, 0.5 hours for education when implementing evidence-
based interventions) 
 
 Other potential team members for consideration regarding their involvement in care 
on the CUSP unit:  Anticipated Time Commitment for each participant is 1-2 hours 
per month (1-2 hours of team meetings) 
1. Nutritionist, Pharmacist, or Respiratory Therapist   
2. Infection Preventionist (recommended for hospitals working on HAI-related 
improvement) 
3. Quality Manager (recommended)  
4. Nurse Manager (if not the Team Leader) 
5. Any other staff who is involved in the direct care of patients on the CUSP unit 
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Appendix B 
Guidelines for Key Messages – Senior Leader Sponsorship 
This document can be used to help CUSP team leaders and members communicate with 
Senior Leaders about their CUSP team activities 
Messages for Senior Leaders from Project Leaders/Nurse Managers/Middle 
Managers  
 My unit/department is engaging in the Basics of CUSP – a comprehensive unit-based 
safety program that engages frontline staff with supervisors, managers, and senior 
leaders to solve patient safety problems identified on their own unit.  
 CUSP helps us identify and take ownership of safety improvement. 
 CUSP was developed by Dr. Peter Pronovost of Johns Hopkins University.  In 2005, 
over 100 ICUs in the state of Michigan nearly eliminated central line associated blood 
stream infections (CLABSIs), and have held a mean rate of zero CLABSIs for over 5 
years.   
 The CUSP model is proven to be effective, and can be implemented in any unit to 
identify and resolve all types of defects while improving patient safety culture on the 
unit. 
 CUSP has five simple steps.  We are working through these steps in six monthly 
training sessions with Tenet and the Center for Patient Safety.  Here are the steps of 
CUSP: 
1. Form a unit CUSP team with executive sponsorship 
2. Educate staff on the Science of Safety 
3. Identify defects using the Staff Safety Assessment (“How will the next patient 
be harmed?  What can be done to prevent that harm from happening?”); 
prioritize defects 
4. Learn from one defect per quarter 
5. Implement team/communication tools 
 We need your help!  CUSP was designed to have an “executive sponsor” – someone 
like you who will be part of our team, work with us, and help us if we run into 
problems that need executive support.  For example, if we find that _<falls>__could 
be eliminated or significantly decreased by changing the type of _<enter 
supply/equipment here>___ then someone like you could help us with that; Or, if we 
identify that the next patient will be harmed on our unit due to pharmacy or lab 
issues, you can help us navigate how to get the right people involved to help us fix the 
problem. 
 Staff members on our unit want you to visit us– to round and let our co-workers and 
patients know that you are supporting our work to make our unit as safe as possible.  
It is a significant morale booster, a personal touch for our patients, and can help us get 
the changes we need put in to place. 
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Messages for Senior Leaders from Bedside Staff – ‘How you can help me to my job 
better” 
 
 I love being a <nurse, RT, etc…> and taking care of my patients. 
 Sometimes it‟s hard for me to do that because of <insert one small issue here: 
missing equipment; lost lab tests; late food trays; etc… > 
 Our unit is learning about a safety program called CUSP and it is teaching us how to 
identify problems on our unit and fix them (by asking ourselves, “How will the next 
patient be harmed?”) – But some problems can only be fixed outside of our unit. 
 Our manager does what he/she can to help with these problems, but sometimes he/she 
cannot remove the barriers to fully solve the problem. 
 I want our patients to be safe, to get them well and sent home as soon as possible.  I 
want to know my family or I will be safe being cared for here.  Will you help us make 
that happen? 
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Appendix C 
CUSP Course Content and Objectives 
 
Session 1:  Overview of CUSP 
 Content Description: 
Review the components of the CUSP:  science of safety education, measure safety 
culture, staff safety assessment, learn from defects, and teamwork and 
communication tools. 
Objectives: 
At the end of this session the learner will be able to: 
1. Discuss the five components of the CUSP 
2. Define how to form a CUSP team 
3. Discuss three strategies to engage the executive 
Session 2: Science of Safety and Staff Safety Assessment 
 Content Description: 
Review the science of safety, including how errors happen and the role of the 
healthcare provider. 
Objectives: 
At the end of this session the learner will be able to: 
1. Discuss 3 reasons medical errors happen 
2. Discuss an example of process redesign to decrease medical errors 
Sessions 3 and 4:  Learning from Defects (LFDs) 
 Content Description: 
 Review the process for learning from defects and define the strategy to identify 
 defects.  
 Objectives: 
 At the end of this session the learner will be able to: 
1. Discuss the components of the LFDs process 
2. Understand how to identify and prioritize defects 
3. Select a defect to apply the LFDs process 
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Session 5:  Understanding the Results of the Hospital Survey on Patient Safety 
 Content Description: 
Review the AHRQ survey components.   Discuss what the results mean and 
develop action plans to improve in areas where score is less than 60% positive. 
Objectives: 
At the end of the session the learner will be able to: 
1. Define the different components of the AHRQ survey 
2. Understand the results from the AHRQ survey 
3. Define 1-2 strategies to address areas on the AHRQ survey that are less than 
60% positive 
 
Session 6:  Introduction to CUSP Teamwork and Communication Tools 
 Content Description: 
 Review different strategies to improve teamwork and communication tools. 
 Objectives: 
 At the end of the session the learner will be able to: 
1. Share three communication and teamwork tool strategies 
2. Discuss strategies to implement at least one of the tools 
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Appendix D 
Central Line Insertion Care Team Checklist 
 
Pt Name_________________ MR# ________________Unit ______________Date/Time ________ 
  
The purpose of this checklist is to check the procedure and environment before, during and after the procedure.  If there 
is a deviation in any of the critical steps, immediately notify the operator and stop the procedure until corrected.  If a 
correction is required, make a check in the „Yes with reminder‟ column and note what correction was made in the 
comment space, if applicable.  Uncorrected deviation and complications of line placement are to be reported in 
hospital-specific incident report.  Contact the Attending/ICU Medical Director if any item on the checklist is not 
adhered to or with any concerns.  PLEASE RETURN COMPLETED FORM TO THE DESIGNATED PERSON 
IN YOUR AREA. 
Please note that in the absence of contraindications, a chest site is preferred over the femoral due to a lower incidence 
of mechanical and infectious complications. 
 
TYPE OF LINE PLACED: _____________________ LOCATION OF LINE: _______________________ 
# OF LUMENS _____________ 
 
Critical Steps 
Yes 
 
Yes With 
Reminder 
Procedure Deviation? 
(complete incident report) Comments: 
Before the procedure, did the operator (person inserting line): 
Explain the procedure to the patient and provide educational materials 
as appropriate.  After the patient has been given an opportunity to ask 
questions to the individual performing the procedure, ensure informed 
consent is provided by the physician. 
  
STOP 
 
Obtain consent for the procedure (signed and witnessed)     STOP   
Perform a time-out and document on hospital form     STOP  
Confirm hand washing/sanitizing immediately prior     STOP   
Operators(s): wear cap, mask, sterile gown/gloves, and eye 
protection? 
    
STOP 
  
Assistant: wear cap, mask, isolation gown and gloves, eye protection 
(if at risk for entering sterile field, use sterile gown and gloves) 
    
 
  
Properly position patient to prevent air embolism 
For Chest/EJ: Trendelenburg (HOB <0 degrees) 
For Femoral or patients where trendelenburg is contraindicated: 
supine 
    
STOP 
  
Prep procedure site (chlorhexidine) for 30 seconds, allow to air dry an 
additional 30 seconds. (groin prep: scrub for 2 minutes and allow to 
dry for 1 minute) 
    
STOP 
  
Allow site to dry        
Use sterile technique to drape from head to toe     STOP   
Utilize local anesthetic and/or sedation      N/A  
During the procedure, did the operator: 
Maintain a sterile field   STOP  
Monitor that lumens were not cut   STOP N/A  
Clamp any ports not used during insertion (to avoid air embolism, 
clamp all but distal port) 
  
STOP 
N/A  
Obtain qualified second operator after 3 unsuccessful sticks (except if 
emergent) 
  
STOP 
N/A  
Aspirate blood from each lumen (to avoid air embolism and ensure 
intravascular placement) 
  
STOP 
 
Transduce CVP or estimate CVP by fluid column (to avoid arterial 
placement)? 
  
STOP 
N/A for fluoroscopy procedures   
After the procedure, did the operator: 
Clean blood from site using antiseptic agent (chlorhexidine), apply 
sterile dressing and apply sterile caps on all hubs 
  
STOP 
 
Verify placement by x-ray (time in SVC/RA junction) (N/A if placed 
under fluoroscopy or in the femoral vein) 
  
STOP 
N/A for fluoroscopy procedures   
 
Operator: _______________________________________         Assistant: ________________________________________ 
New line    
Rewire  
  
Rewire  
 55
  
Appendix E 
Biomedical IRB Notice of Excluded Activity 
 
 
 
Biomedical IRB 
Notice of Excluded Activity 
 
 DATE: March 22, 2013  
 
TO: Mr. Michael Basinger, Nursing 
  
FROM: Office of Research Integrity – Human Subjects  
 
RE: Notification of IRB Action 
  
Protocol Title: The Reduction of Central Line-Associated Bloodstream Infections 
(CLABSIs) in Intensive Care Units (ICUs) Through the Implementation of the 
Comprehensive Unit-Based Safety Program (CUSP)  
Protocol# 1303-4410M  
  
This memorandum is notification that the project referenced above has been reviewed as 
indicated in Federal regulatory statutes 45CFR46.  
 
The protocol has been reviewed and deemed excluded from IRB review. It is not in need of 
further review or approval by the IRB. 
  
Any changes to the excluded activity may cause this project to require a different level of IRB 
review. Should any changes need to be made, please submit a Modification Form.  
 
If you have questions or require any assistance, please contact the Office of Research 
Integrity – Human Subjects at IRB@unlv.edu or call 895-2794. 
 
 
 
Office of Research Integrity – Human Subjects 
4505 Maryland Parkway • Box 451047 • Las Vegas, Nevada 89154-1047 
(702) 895-2794 • FAX: (702) 895-0805 
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Appendix F  
Team Ground Rules Sample 
 
 
 Members commit to active and regular participation in meetings and activities.   
o All members agree to attend all meetings. When someone cannot attend that person 
will contact the team leader 24 hours in advance of meeting, if possible 
 Members come to all meetings with assignments completed, prepared to productively 
contribute to discussions and decisions 
 Meetings will be started on time if at least 80% of team is present 
 We will discuss best decision making model for each situation.  We will support 
decisions made by the group 
 We will use data whenever possible as the „ultimate authority‟ 
 Honest disagreements are welcome as long as people treat each other with respect. 
 All members will be given an opportunity to contribute to discussion and decision. 
 Members will listen to others, respect their opinions and not interrupt 
 Members monitor minutes for key decisions and promptly communicate to the 
staff/unit they represent 
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Appendix G 
CUSP Team Meeting #1 Agenda Sample 
 
This document is a Sample Agenda for the CUSP team leader to customize for the first 
CUSP Team Meeting at their organization 
 
Team Meeting 1 
 
Sample Agenda 
 
1. Overview of CUSP (NOTE TO LEADER – please use the slides from Coaching 
Call 1 held on February 26, 2013) 
 
2. Physician Engagement module (NOTE TO LEADER – the URL to the audio file 
link and slides are provided on team leader checklist) 
 
3. Science of Safety Video – (NOTE TO LEADER – the URL for the audio file and 
slides are on the team leader checklist) 
 
4. Plan to educate all unit staff on the Science of Safety using the URL link to the 
video or the DVD.  (NOTE TO LEADER – the URL for the video  and slides are 
on the team leader checklist) 
 
Consider providing the CUSP education as follows: 
 
- During regularly scheduled staff meetings 
- Set up a computer in a designated location with a shortcut on the Desktop of 
the computer to CUSP materials 
- During shift huddles (consider dividing the video content into small segments 
to view at different huddle sessions) 
 
5.  Documentation of who attends the CUSP training? 
 
- Work with your education department to meet facility requirements 
 
6.  How will you educate future unit staff members on the Science of Safety?   
Consider the following –  
- New employee unit orientation 
- Assigning a preceptor for new staff to share components of CUSP 
-  Include in annual competencies  
 
7. Adjourn 
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Appendix H 
CUSP Team Meeting #1 or #2 Agenda Sample 
 
This document is a Sample Agenda for the CUSP team leader to customize for the first or 
second CUSP Team Meeting at their organization 
 
Team Meeting 1 or 2 
 
Sample Agenda 
 
Recommended Documents for Team Meeting: 
 
From Coaching Call 1, 02/26/2013 (if this is your first team meeting): 
 The Basics of CUSP Session 1 PowerPoint Presentation (to provide an 
overview of CUSP to team) 
 
From Coaching Call 2, 03/26/2013: 
 Document - The Basics of CUSP Session 2 PowerPoint Presentation (to 
provide an overview of the Staff Safety Assessment and HSOPS) 
 Document  – Team Ground Rules Sample 
 Document  – Staff Safety Assessment 
 Document 6 – Science of Safety Training Sample 1 
 Document 7 – Science of Safety Training Sample 2 
 
1.  Overview of CUSP (can use slides from Coaching Call 1 on 02/26/2013) 
 
2. Discuss and set Team Ground Rules (see Document 2 for sample rules) 
 
3. Listen to the Physician Engagement module (audio file link and slides on team 
leader checklist from Coaching Call 1, 02/26/2013) – can do this together during 
team meeting or individually 
 
4. View the Science of Safety video (audio file link and slides on team leader 
checklist from Coaching Call 1, 02/26/2013) – can do this together during team 
meeting or individually 
 
5. Develop plan for educating all unit staff on the Science of Safety and 
administering the Staff Safety Assessment  
 
6. Plan to educate all unit staff on the Science of Safety using the URL link to the 
video or the DVD.  (NOTE TO LEADER – the URL for the video  and slides are 
on the team leader checklist from Coaching Call 1 on 02/26/2013 ) 
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Consider providing the CUSP education as follows: 
 
During regularly scheduled staff meetings 
Set up a computer in a designated location with a shortcut on the Desktop of the 
computer to CUSP materials 
During shift huddles (consider dividing the video content into small segments to 
view at different huddle sessions) 
 
a. Choose a method to do the Staff Safety Assessment 
i. Can be done immediately following staff education on the Science 
of Safety (recommended) 
ii. How will the staff assessment forms be collected? 
   1.  Box on the unit that staff puts the survey into 
2.  Other method? 
iii. Who on the CUSP team will collect and collate the results?  
 
b. How will you educate future unit staff members on the Science of 
Safety?   Consider the following –  
- New employee unit orientation 
- Assigning a preceptor for new staff to share components of CUSP 
-  Include in annual competencies  
 
7. Overview of Hospital Survey on Patient Safety – unit culture survey  
a. Develop plan to reach the goal of a 60% response rate 
i. Getting the word out 
ii. Rewards/recognition (this is a good area for your executive 
champion to assist) 
b. Review HSOPS Timeline  
 
8. Review action items/assign tasks and deadlines 
 
9. Adjourn 
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Appendix I 
CUSP Team Meeting #2 or #3 Agenda Sample 
 
This document is a Sample Agenda for the CUSP team leader to customize for the second 
or third CUSP Team Meeting at their organization 
 
Team Meeting 2 or 3 
Sample Agenda 
 
Recommended Documents for Team Meeting: 
 
From Coaching Call 2: 
 Document – The Basics of CUSP Session 2 PowerPoint Presentation (to 
provide an overview of the Staff Safety Assessment and HSOPS) 
 Document – Team Ground Rules Sample 
 Document – Staff Safety Assessment 
 
From Coaching Call 3: 
 Document – The Basics of CUSP Session 3 PowerPoint Presentation (to 
provide an overview of the Revised HSOPS Timeline and the Learning 
from Defects Tool) 
 Document – Learning From Defects Tools 
 Document – Article on Learning from Defects 
 
1. Discuss and set Team Ground Rules (see Document from Coaching Call 2) 
 
2. Collate and prioritize results of the Staff Safety Assessment (Document from 
Coaching Call 3 – slides 12-18) 
 
3. Select one defect to take through the Learning from a Defect Tool.  Begin the 
Learning from a Defect Process (Document from Coaching Call 3 – slides 19-43; 
Documents from Coaching Call 3 – Learning from Defects Tools) 
 
4. Homework for all team members – read Document from Coaching Call 3 – 
Article on Learning from Defects 
 
5. Review action items/assign tasks and deadlines 
 
6. Adjourn 
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Appendix J 
CUSP Team Meeting #3 or #4 Agenda Sample 
 
This document is a Sample Agenda for the CUSP team leader to customize for the third 
or fourth CUSP Team Meeting at their organization 
 
Team Meeting 3 or 4 
Sample Agenda 
 
Recommended Documents for Team Meeting: 
 
From Coaching Call 3, 04/23/2013 
 Document – The Basics of CUSP Session 3 PowerPoint Presentation (to 
provide an overview of HSOPS and the Learning from Defects Tool) 
 Document – Learning From Defects Tool 
 Document – Article on Learning from Defects 
 
From Coaching Call 4, 05/28/2013 
 Document – Learning From Defects Tool 
 Document – Case Summary Learning Tool 
 
1. Collate and prioritize results of the Staff Safety Assessment (Document from 
Coaching Call 3 – slides 8-10) 
 
2. Select one defect to take through the Learning from a Defect Tool.  Begin the 
Learning from a Defect Process (Document from Coaching Call 3 – slides 11-27; 
Document from Coaching Calls 3& 4 – Learning from Defects Tool) 
 
3. Complete the Case Summary Learning Tool (Document from Coaching Call 4) 
 
4. Review action items/assign tasks and deadlines 
 
5. Adjourn 
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Appendix K 
CUSP Team Meeting #4 or #5 Agenda Sample 
 
This document is a Sample Agenda for the CUSP team leader to customize for the fourth 
or fifth CUSP Team Meeting at their organization 
 
Team Meeting 4 or 5 
Sample Agenda 
 
Recommended Documents for Team Meeting: 
 
From Coaching Call 3, 
 Document – The Basics of CUSP Session 3 PowerPoint Presentation (to 
provide an overview of the Learning from Defects Tool) 
 
From Coaching Call 4,  
 Document – Learning From Defects Tool 
 Document – Case Summary Learning Tool 
 
From Coaching Call 5, 
 Document – The Basics of CUSP Session 5 PowerPoint Presentation (to 
provide the method for patient safety action planning) 
 
 
1. Select one defect to take through the Learning from a Defect Tool.  Begin the 
Learning from a Defect Process (Document from Coaching Call 3 – slides 11-27; 
Document from Coaching Call 3 – Learning from Defects Tool) 
 
2. Complete the Case Summary Learning Tool (Document from Coaching Call 4) 
 
3. Review HSOPS/patient safety survey results; begin action planning 
 
4. Review action items/assign tasks and deadlines 
 
5. Adjourn 
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Appendix L 
CUSP Team Meeting #5 or #6 Agenda Sample 
 
This document is a Sample Agenda for the CUSP team leader to customize for the fifth or 
sixth CUSP Team Meeting at their organization 
 
Team Meeting 5 or 6 
Sample Agenda 
 
Recommended Documents for Team Meeting: 
 
From Coaching Call 4,  
 Document – Learning From Defects Tool 
 Document – Case Summary Learning Tool 
 
From Coaching Call 5,  
 Document – The Basics of CUSP Session 5 PowerPoint Presentation (to 
provide the method for patient safety action planning) 
 
From Coaching Call 6,  
 Document – The Basics of CUSP Session 6 PowerPoint Presentation (for 
an overview of communication/teamwork tools) 
 
 
1. Complete the Case Summary Learning Tool (Document from Coaching Call 4) 
 
2. Review HSOPS/patient safety survey results; begin action planning 
 
3. Review communication/teamwork tools; plan to implement at least one. 
 
4. Establish a process to Learn from One Defect monthly.  
 
5. Review action items/assign tasks and deadlines 
 
6. Adjourn 
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Appendix M 
Staff Safety Assessment – CUSP 
 
 
 
Purpose of this form:  The purpose of this form is to tap into your knowledge and 
experiences at the frontlines of patient care to find out what risks are present on your unit 
that have or could jeopardize patient safety.    
 
Who should complete this form:  All health care providers within the ICU 
 
How to complete this form:  Provide as much detail as possible when answering the 2 
questions.  Drop off your completed safety assessment form in the location designated by 
the CUSP improvement team with your job category, date, and unit (name is optional).   
 
When to complete this form:  Assessing safety should be considered an iterative 
process with no defined end (like a moving bicycle wheel). Thus, it can be filled out by 
any health care provider in the ICU at any time.  At the very least, all health care 
providers should complete this form semiannually.   
 
 
Name (optional):  __________________________________________  
Job Category:  ____________________________________________  
Date:   __________________  
Unit:   __________________  
 
Please describe how you think the next patient in your unit/clinical area will be 
harmed. 
 
 
 
 
 
Please describe what you think can be done to prevent or minimize this harm.  
 
 
 
 
 
Thank you for helping improve safety in your workplace! 
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Appendix N 
Attendance Sheet – Science of Safety/Safety Assessment  
 
 
Unit Name: _____________________________________ 
              Safety   
Name Date of Training Science Staff 
   of Safety 
   Safety Assess 
 
___________________________________ ____________________ ____ ____ 
 
___________________________________ ____________________ ____ ____ 
  
___________________________________ ____________________ ____ ____ 
 
___________________________________ ____________________ ____ ____ 
 
___________________________________ ____________________ ____ ____ 
 
___________________________________ ____________________ ____ ____ 
  
___________________________________ ____________________ ____ ____ 
 
___________________________________ ____________________ ____ ____ 
 
___________________________________ ____________________ ____ ____ 
 
___________________________________ ____________________ ____ ____ 
  
___________________________________ ____________________ ____ ____ 
 
___________________________________ ____________________ ____ ____ 
 
___________________________________ ____________________ ____ ____ 
 
___________________________________ ____________________ ____ ____ 
  
___________________________________ ____________________ ____ ____ 
 
___________________________________ ____________________ ____ ____ 
 
___________________________________ ____________________ ____ ____ 
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Appendix O 
Learn From Defects Tool Worksheet 
 
 
Date: 
 
Attendees: 
 
What happened?  (brief description) 
 
 
 
 
Why did it happen?  (what factors contributed) 
 
+ 
What prevented it from being worse?  
 
 
 
 
 
 
 
 
 
 
 
- 
What happened to cause the defect? 
 
What can we do to reduce the risk of it happening with a different person? 
 
 
 
 
 
How will we know the risk is reduced? 
 
 
 
 
 
With whom shall we share our learning? 
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Appendix P 
CUSP Webinar Team Attendance List 
 
February – July 2013 
Hospital ____________________________ 
Unit________________________________ 
Team Member Webinar 
#1  
 2/26/13 
Webinar 
#2 
3/26/13 
Webinar 
#3 
4/23/13 
Webinar 
#4 
5/28/13 
Webinar 
#5 
6/25/13 
Webinar 
#6 
7/23/13 
TL -       
MD -       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
 
 
Notes: 
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Appendix Q 
Permission 
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Appendix R 
Figures and Tables 
Figure 5.  Model of Five Stages in the Innovation-Decision Process 
 
 
 
Note.  The innovation-decision process is the process through which an individual (or 
other decision-making unit) passes from first knowledge of an innovation, to forming an 
attitude toward the innovation, to a decision to adopt or reject, to implementation of the 
new idea, and to confirmation of this decision.  Adapted from “Diffusion of Innovations 
(5
th
 Ed.)” by Everett M. Rogers, 2003, p.170.  Copyright 2003 by Free Press, A Division 
of Simon & Schuster, Inc.  Reprinted with permission. 
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Table 3 
Diffusion of Innovations Linkage to CUSP Steps 
 
CUSP 
 
DIFFUSION OF 
INNOVATIONS 
 
DIFFUSION OF 
INNOVATIONS 
 
CUSP Steps 
 
Innovation Attributes 
 
Innovation-Decision 
Process Stages 
Step 1:  Educate on the 
science of safety 
Relative Advantage 
Compatibility 
Knowledge 
Step 2:  Identify defects/  
patient safety hazards 
Relative Advantage 
Compatibility 
Knowledge 
Persuasion 
Step 3:  Partner senior 
executive with unit 
Relative Advantage 
Compatibility 
Observability 
Persuasion 
Decision 
 
Step 4:  Learn from defects  Relative Advantage 
Observability 
Complexity 
Trialability 
Knowledge 
Persuasion 
Decision 
Implementation 
Step 5:  Implement 
teamwork and 
communication tools 
Complexity 
Trialability 
Decision 
Implementation 
 
Innovation Attributes: 
Relative Advantage - The degree to which an innovation is perceived as being advantageous 
Compatibility - The degree to which an innovation is perceived as being consistent with values and norms 
of the         potential adopters 
Observability - The degree to which the results of an innovation are visible to others 
Complexity - The degree to which an innovation is perceived as difficult to understand and use 
Trialability - The degree to which an innovation can be experimented with on a limited basis 
 
Innovation-Decision Process Stages: 
Knowledge - Awareness of an innovation and understanding how it functions 
Persuasion - Formation of favorable or unfavorable attitudes toward the innovation 
Decision - Activities that lead to adoption or rejection of an innovation 
Implementation - Putting the innovation into use 
 
Note.  Innovation attributes and stages of the innovation-decision process impact the rate 
of adoption.  Linkage of the innovation attributes and innovation-decision stages to the 
CUSP steps.  Adapted from Rogers, E. M. (2003). Diffusion of Innovations (5
th
 Ed.). New 
York, NY: Free Press.   
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Table 4 
Detailed Timeline 
 
Time Period Activities 
January 2013  Review, finalize, and sign the Center 
for Patient Safety proposal for 
training and services to implement 
the CUSP 
 Draft process steps for each 
education webinar session and 
assign accountability 
 Determine technology to be used for 
the education webinar series 
 Determine dates and times for 
preplanning and post evaluation calls 
for each education webinar 
 Send memo/correspondence to all 
Chief Nursing Officers (CNOs), 
Quality Directors (QDs), IPs, & Risk 
Managers (RMs) regarding the 
CLABSI/CUSP initiative 
 Obtain final September 2012 – 
January 2013 CLABSI rates as 
baseline data 
February 2013 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Send memo/correspondence to all 
Chief Executive Officers (CEOs) 
regarding the CLABSI/CUSP 
initiative 
 Send team membership form and 
request to all CNOs for assignment, 
completion, and return 
 Complete process requirements to 
offer continuing education units 
(CEUs) to participants for 
attendance at education webinars 
 Create share point site on the 
healthcare system intranet to locate 
all CUSP education and training 
materials 
 Send share point site link to all 
CNOs, QDs, IPs, RMs, and other 
CUSP team members 
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Time Period Activities 
February 2013 (continued)  Collect and log all hospital CUSP 
team membership forms 
 Review and finalize draft materials 
for webinar #1 
 Post all materials for webinar #1 on 
the share point site one week prior to 
call 
 Conduct pre-and post-webinar calls 
on 2/11/13 and 2/26/13 
 Conduct webinar #1 on 2/26/13 
 Assign “homework” to CUSP teams 
March 2013  Review and finalize draft materials 
for webinar #2 
 Post all materials for webinar #2 on 
the share point site one week prior to 
call 
 Conduct pre-and post-webinar calls 
on 3/18/13 and 3/26/13 
 Conduct webinar #2 on 3/26/13 
 Assign “homework” to CUSP teams 
 Obtain IRB Exclusion from the 
UNLV Office of Research Integrity-
Human Subjects 
April 2013  Review and finalize draft materials 
for webinar #3 
 Post all materials for webinar #3 on 
the share point site one week prior to 
call 
 Conduct pre-and post-webinar calls 
on 4/15/13 and 4/23/13 
 Conduct webinar #3 on 4/23/13 
 Assign “homework” to CUSP teams 
 Defend DNP Project Proposal at 
UNLV on 4/11/13 
May 2013  Review and finalize draft materials 
for webinar #4 
 Post all materials for webinar #4 on 
the share point site one week prior to 
call 
 Conduct pre-and post-webinar calls 
on 5/13/13 and 5/28/13 
 Conduct webinar #4 on 5/28/13 
 Assign “homework” to CUSP teams 
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Time Period Activities 
June 2013  Review and finalize draft materials 
for webinar #5 
 Post all materials for webinar #5 on 
the share point site one week prior to 
call 
 Conduct pre-and post-webinar calls 
on 6/10/13 and 6/25/13 
 Conduct webinar #5 on 6/25/13 
 Assign “homework” to CUSP teams 
July 2013  Review and finalize draft materials 
for webinar #6 
 Post all materials for webinar #6 on 
the share point site one week prior to 
call 
 Conduct pre-and post-webinar calls 
on 7/8/13 and 7/23/13 
 Conduct webinar #6 on 7/23/13 
August 2013  Conduct follow-up session with all 
CUSP teams 
 Develop process with participating 
hospital IPs to provide the number of 
CLABSIs in the ICUs to the CUSP 
teams each month 
September 2013  Develop plans to incorporate the 
CUSP into new employee 
orientation 
 Review 3rd Quarter 2013 CLABSI 
rates as a preliminary measure of 
progress and success 
 Review monthly CLABSI rate 
numbers from all participating 
hospital ICUs 
October 2013  Conduct follow-up session with all 
CUSP teams 
 Review monthly CLABSI rate 
numbers from all participating 
hospital ICUs 
November – December 2013  Develop plans to incorporate the 
CUSP framework into the corporate 
and hospital QI plans for use in other 
quality initiatives 
 Review monthly CLABSI rate 
numbers from all participating 
hospital ICUs 
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Time Period Activities 
January 2014  Conduct follow-up session with all 
CUSP teams 
 Review monthly CLABSI rate 
numbers from all participating 
hospital ICUs 
 Obtain and review August - 
December 2013 CLABSI rates 
 Begin data analysis process by 
comparing pre-and post-
implementation CLABSI rate data 
February 2014 
 
 
 
 
 
 Complete data analysis and 
interpretation of pre- and post-
implementation of CLABSI rates 
 Begin evaluation process with 
identification of findings 
 Present findings to corporate 
leadership and hospitals system wide 
March 2014  Complete final DNP Project writing 
and submit to Project Chair and 
Committee Members 
 Defend final DNP Project at UNLV 
on March 24, 2014 
 Submit approved final DNP Project 
to the Graduate College of UNLV  
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Table 5 
Team Leader Checklist – Webinar #1 
ACTIONS RESOURCES 
 Choose a unit in your hospital to 
implement CUSP 
 The unit may be designated by your 
organization for participation in the Basics of 
CUSP project. 
 If not, consider units that have strong 
leadership, passion and commitment to 
improve the culture for safety and teamwork 
on their unit.  Also consider units that have a 
need to improve aspects of clinical safety. 
 Recruit a unit-based CUSP team  Document - Recommendations for Unit-based 
CUSP Teams  
 Recruit an executive sponsor  Document – Key Messages for Executives 
 Schedule CUSP team meetings – 
once or twice per month 
 Schedule team meetings for at least 6 months 
for the Basics of CUSP series. 
 Listen/view the “Physician 
Engagement” module 
 Link to Audio File:   
http://www.ahrq.gov/cusptoolkit/videos/02e_p
hys_engagement/index.html 
 Link to Slides:  
http://www.ahrq.gov/cusptoolkit/2assembletea
m/assembleteamnotes.htm#slide15 
 Consider listening/viewing one of 
the “Science of Safety” videos 
 Science of Safety Videos:  
http://www.ahrq.gov/cusptoolkit/videos/04a_s
cisafety/index.html  
http://dukepatientsafetycenter.com/video.asp 
 
 Facilitate first team meeting (for 
teams that are established this 
month) 
 CUSP Team meeting to be held prior to the 
Basics of CUSP Session #2 
 Document – Sample Agenda for your CUSP 
Team Meeting 1 
 Team members listen/view the 
Physician Engagement module and 
the Science of Safety video 
 See links to audio files/slides above 
 If your first team meeting is happening this 
month, can view as a group 
 If first team meeting will be next month, 
consider asking team members to view 
individually 
*In order to stay on track during this 6-month course, actions listed on the Team Leader Checklist should 
be considered homework,” to be completed prior to next month‟s coaching call. 
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Table 6 
Team Leader Checklist – Webinar #2 
ACTIONS RESOURCES 
 Complete any action items that 
you did not complete on the Team 
Leader Monthly Checklist for 
Coaching Call 1 
 
 Facilitate team meeting 1 or 2 
(depending on whether you had 
your first team meeting last 
month) 
 Document – Team Ground Rules Sample 
 Document – Staff Safety Assessment 
 Document – Sample Agenda for CUSP 
Team Meeting 1 or 2 
 Document – Science of Safety Training 
Sample 1 
 Document – Science of Safety Training 
Sample 2 
 Roll out Science of Safety 
Training and the Staff Safety 
Assessment to Unit Staff  
 Document – Attendance Sheet for 
Science of Safety Training 
 Collate results of the Staff Safety 
Assessment  
 You will be instructed on what to do with 
your collated results during Coaching Call 
3  
 
*In order to stay on track during this 6-month course, actions listed on the Team Leader Checklist should 
be considered “homework,” to be completed prior to next month‟s coaching call.   
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Table 7 
Team Leader Checklist – Webinar #3 
ACTIONS RESOURCES 
 Complete any action items that 
you did not complete on the 
Team Leader Monthly Checklist 
for Coaching Call 2 
 
 Facilitate team meeting 2 or 3 
(depending on whether you had 
your first team meeting) 
 Document – Sample Agenda for CUSP Team 
Meeting 2 or 3 
 Document – Learning From Defects Tools 
 Document – Article on Learning from Defects 
 Prioritize results of the Staff 
Safety Assessment; choose a 
defect to take through the 
Learning from a Defect Tool 
 Document – Coaching Call 3 Presentation (slides 
12-18) 
 Document – Sample Agenda for CUSP Team 
Meeting 2 or 3 
 Begin working through the 
Learning from a Defect Tool 
(we will cover this step in 
Coaching Call 4 as well) 
 Document – Coaching Call 3 Presentation (slides 
19-43) 
 Note:  “Summarize and Share Findings” (slide 
40) will be covered during Coaching Call 4 (do 
not do this month) 
 Document – Sample Agenda for CUSP Team 
Meeting 2 or 3 
 Document – Learning From Defects Tool 
*In order to stay on track during this 6-month course, actions listed on the Team Leader Checklist should 
be considered “homework,” to be completed prior to next month‟s coaching call.   
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Table 8 
Team Leader Checklist – Webinar #4 
ACTIONS RESOURCES 
 Complete any action items that 
you did not complete on the Team 
Leader Monthly Checklist for 
Coaching Call 3 
 
 Facilitate team meeting 3 or 4 
(depending on whether you had 
your first team meeting) 
 Document – Sample Agenda for CUSP 
Team Meeting 3 or 4 
 Document – Learning From Defects Tool 
 Document – Case Summary Learning Tool 
 Finish prioritizing results of the 
Staff Safety Assessment; choose a 
defect to take through the Learning 
from a Defect Tool 
 Document – Sample Agenda for CUSP 
Team Meeting 3 or 4 
 Work through the Learning from a 
Defect Tool 
 Document – Learning From Defects Tool 
 Document – Case Summary Learning Tool 
 
 Complete the Post-Coaching Call 4 
survey 
 This will be emailed to you by Wednesday, 
May 29th 
 Please complete survey by Friday, June 7th 
 
*In order to stay on track during this 6-month course, actions listed on the Team Leader Checklist should 
be considered “homework,” to be completed prior to next month‟s coaching call.    
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Table 9 
Team Leader Checklist – Webinar #5 
ACTIONS RESOURCES 
 Complete any action items that 
you did not complete on the Team 
Leader Monthly Checklist for 
Coaching Call 4 
 
 Facilitate team meeting 4 or 5 
(depending on when you had your 
first team meeting) 
 Document – Coaching Call 5 Presentation 
 Document – Sample Agenda for CUSP Team 
Meeting 4 or 5 
 Document – Learning From Defects Tool 
(from call 4) 
 Document – Case Summary Learning Tool 
(from call 4) 
 Work through the Learning from a 
Defect Tool 
 Document – Learning From Defects Tool 
(from call 4) 
 Document – Case Summary Learning Tool 
(from call 4) 
 Begin patient safety survey results 
action planning 
 Document – Coaching Call 5 Presentation 
 Your HSOPS or other patient safety culture 
survey results 
 Complete the Post-Coaching Call 
5 survey 
 This will be emailed to you on Wednesday, 
June 26th 
 Please complete the survey by July 5th 
 
*In order to stay on track during this 6-month course, actions listed on the Team Leader Checklist should 
be considered “homework,” to be completed prior to next month‟s coaching call.    
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Table 10 
Team Leader Checklist – Webinar #6 
ACTIONS RESOURCES 
 Complete any action items that 
you did not complete on the Team 
Leader Monthly Checklist for 
Coaching Call 5 
 
 Facilitate team meeting 5 or 6 
(depending on whether you had 
your first team meeting) 
 Document – Presentation for Coaching Call 
6 
 Document – Sample Agenda for CUSP 
Team Meeting 5 or 6 
 
 Work through the Learning from a 
Defect Tool 
 Coaching Call 3 and 4 Resources 
 
 Begin patient safety survey results 
action planning 
 Document – Coaching Call 5 Presentation 
 Your HSOPS or other patient safety culture 
survey results 
 Plan to implement at least one 
team and communications tool 
 Document – Coaching Call 5 Presentation 
 
 Commit to Learning from One 
Defect per Month 
 Coaching Call 3 and 4 Resources 
 
 Keep your CUSP team meetings 
going! 
 
*In order to stay on track during this 6-month course, actions listed on the Team Leader Checklist should 
be considered “homework,” to be completed prior to next month‟s coaching call  
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Table 11 
Poisson 95 % Confidence Intervals by Hospital 
Hospital 
Code 
Pre-CUSP 
Implementation 
Rate 
Post-CUSP 
Implementation 
Rate 
Difference in 
Rates 
Lower 
Limit  
95 % CI 
Upper 
Limit  
95% CI 
BAR 0.801 0.000 0.801 -0.769 2.372 
CCA 0.000 0.000 0.000 0.000 0.000 
CGH 0.000 4.418 -4.418 -9.418 0.581 
CYF 1.381 0.000 1.381 -1.326 4.088 
DES 1.391 1.357 0.034 -2.166 2.234 
DHF 0.000 0.000 0.000 0.000 0.000 
DHW 0.000 1.733 -1.733 -5.130 1.664 
ECH 0.000 0.000 0.000 0.000 0.000 
FLO 1.658 0.000 1.658 -1.592 4.909 
FRH 2.584 0.000 2.584 -2.481 7.649 
FRM 0.566 0.000 0.566 -0.544 1.676 
FVR 1.468 0.000 1.468 -0.193 3.129 
GBH 1.605 0.000 1.605 0.416 2.794 
GSM 1.926 1.313 0.612 -2.227 3.451 
HAH 2.628 1.361 1.268 -3.247 5.782 
HIA 1.992 1.749 0.243 -2.757 3.243 
HNM 5.174 1.637 3.537 -0.037 7.112 
IND 0.000 0.000 0.000 0.000 0.000 
LAK 0.000 0.000 0.000 0.000 0.000 
LOM 0.000 0.000 0.000 0.000 0.000 
LPX 0.000 0.000 0.000 0.000 0.000 
MAN 3.390 0.000 3.390 -3.254 10.034 
MOD 0.932 0.826 0.107 -1.200 1.414 
NFR 0.886 0.000 0.886 -0.850 2.622 
NMC 0.000 0.000 0.000 0.000 0.000 
NOS 3.962 2.941 1.021 -2.595 4.638 
PBG 0.564 0.000 0.564 -0.218 1.346 
PGH 0.414 1.119 -0.705 -2.456 1.046 
PLA 0.000 10.695 -10.695 -25.518 4.128 
PMC 0.000 0.810 -0.810 -2.397 0.777 
PPH 0.322 0.000 0.322 -0.124 0.769 
PRV 1.018 0.000 1.018 -0.393 2.428 
PSH 3.376 4.854 -1.479 -7.273 4.316 
SES 0.000 0.000 0.000 0.000 0.000 
SFH 0.918 0.897 0.021 -1.432 1.474 
SIE 0.000 0.000 0.000 0.000 0.000 
SMH 0.291 0.445 -0.154 -1.197 0.889 
SRE 1.927 1.767 0.160 -2.402 2.722 
SYL 0.000 0.000 0.000 0.000 0.000 
TWI 2.445 0.000 2.445 -2.347 7.237 
WBO 0.000 0.000 0.000 0.000 0.000 
System 1.101 0.739 0.361 0.021 0.701 
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Table 12 
 
CLABSI Rates and Webinar Attendance 
  
 
Category-Poor Attendance: 
 
 
Category- Fair Attendance: 
Pre-CUSP Incidence Rate 0.4792 
95% Confidence Interval 0.2682 to 0.7904 
Post-CUSP Incidence Rate 0.1546 
95% Confidence Interval 0.0421 to 0.3957 
Incidence Rate Difference 0.3247 
95% Confidence Interval 0.0245 to 0.6248 
P-value P = 0.0340 
Incidence Rate Ratio 3.1005 
95% Confidence Interval 0.9877 to 12.8339 
 
Category- Good Attendance: 
Pre-CUSP Incidence Rate 1.8961 
95% Confidence Interval 1.1883 to 2.8707 
Post-CUSP Incidence Rate 0.8903 
95% Confidence Interval 0.4269 to 1.6373 
Incidence Rate Difference 1.0057 
95% Confidence Interval 0.0345 to 1.9769 
P-value P = 0.0424 
Incidence Rate Ratio 2.1297 
95% Confidence Interval 0.9677 to 5.0377 
 
 
Pre-CUSP Incidence Rate 1.5437 
95% Confidence Interval 1.0173 to 2.2459 
Post-CUSP Incidence Rate 1.5206 
95% Confidence Interval 0.9743 to 2.2626 
Incidence Rate Difference 0.02303 
95% Confidence Interval -0.8194 to 0.86545 
P-value P = 0.9573 
Incidence Rate Ratio 1.0151 
95% Confidence Interval 0.5639 to 1.8379 
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